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Magnetic resonance imaging (MRI) is regularly used to obtain anatomical images 
that have greatly advanced biomedical research and clinical health care today, but the full 
potential of MRI in providing functional, physiological, and molecular information is 
only beginning to emerge. The goal of magnetic resonance molecular imaging is to 
further understand and develop approaches to MRI to acquire information on the 
molecular level. This work is focused on ways to enhance the effect of iron oxide based 
nanoparticles on the MR signal, to study alternative approaches to generating contrast 
with superparamagnetic iron oxide nanoparticles (SPIO), and to develop a genetic marker 
for MRI which results in the biological production of magnetic nanoparticles. The work 
presented in this dissertation is divided into three main sections: 
 
Elucidation of the contribution of size and coating properties to magnetic nanoparticle 
induced proton relaxation. 
In order to maximize the contrast generated from such particles without 
increasing their size, new methods to increase their effect on relaxivity must be 
developed. Experimental data obtained on a new class of biocompatible particles are 
presented, along with simulated data. The effects on relaxivity of coating size, proton 
exchange, and altered diffusion are examined. Simulations are presented confirming the 
effect of particle coatings on clustering-induced relaxivity changes, and an experimental 
system demonstrating the clustering effect is presented. 
 
 xi
Development of a diffusion-dependent, off-resonance imaging protocol for magnetic 
nanoparticles. 
This work demonstrates an alternative approach, termed off-resonance saturation 
(ORS), for generating contrast sensitive to SPIO nanoparticles. This method leads to a 
calculated contrast that increases with SPIO concentration. Experimental data 
demonstrate that in the presence of these particles, an off-resonance effect exists, that is 
distinct from the magnetization transfer (MT) effect, and is highly dependent on 
diffusion. Data show that the dependence on water diffusion becomes most significant at 
rates of 0.5 × 10-9 m2/s and slower. The dependence of the off-resonance effect on off-
resonance frequency and particle concentration are also investigated. The data suggest a 
useful frequency offset range of 500 Hz < |∆ω| < 1500 Hz at 3T. This approach may be 
especially useful in organs and diseases in which diffusion may be altered by pathologies. 
 
 
Development of a genetic MRI marker via in vivo magnetic nanoparticle synthesis  
This work seeks to provide a gene expression marker for MRI based on bacterial 
magnetosomes, tiny magnets produced by naturally occurring magnetotactic bacteria. 
Here, magA is expressed in a commonly used human cell line, 293FT, resulting in the 
production of magnetic, iron oxide nanoparticles by these cells. MRI shows that these 
particles can be formed in vivo utilizing endogenous iron and can be used to visualize 
cells positive for magA. These results demonstrate that magA alone is sufficient to 
produce magnetic nanoparticles and that it is an appropriate candidate for an MRI 








 Magnetic resonance imaging (MRI) is regularly used to construct an image based 
on the intrinsic contrast provided from the relaxation of spin of hydrogen atoms. These 
images provide an accurate anatomical picture that has greatly advanced health care 
today. Clinically, the images produced by MRI are invaluable, but the full potential of 
using MRI in acquiring functional, physiological, and molecular information is only 
beginning to be realized. The goal of this work is to further understand and develop 
approaches to magnetic resonance imaging to acquire information on the molecular level, 
a field termed molecular imaging.  
 
Molecular imaging refers to the study of cellular and molecular events through 
noninvasive investigation [1]. Bringing molecular imaging to MRI requires generating 
contrast specific to information on the molecular level that is also sensitive enough to be 
observed at the voxel level. Gadolinium ion-based contrast agents are required to be 
present in relatively high concentrations, on the order of millimoles.  Targeted in vivo 
imaging with MRI, however, often requires contrast agent compounds to be effective at 
concentrations on the order of 10 µM [2]. It is therefore desirable to obtain contrast 
agents in which a small number of bindings to targets will be sufficient to generate 
contrast. Iron oxide nanoparticles provide the possibility of detection at the single particle 
1 
level [3]. These particles, however, are at the micrometer size. Such large particles are 
likely to interfere with normal cellular processes limiting their application to cellular and 
molecular imaging. It is therefore important to devise methods for imaging small 
particles, on the order of nanometers in size. This is especially important for intracellular 
studies. 
 
 Here we will begin by looking at contrast in MRI. The parameters described that 
are responsible for generating the intrinsic contrast between tissues in MRI are the same 
parameters affected by synthetic contrast agents. This will help to understand the 
mechanism of contrast agents and the reason superparamagnetic iron oxide nanoparticles 
are an appropriate choice for molecular imaging.  
 
 Following this chapter, Chapter 2 will discuss studies involving synthetic 
nanoparticles and the effect of their coatings on relaxivity. Chapter 3 will discuss an 
alternative approach to imaging with superparamagnetic particles utilizing off-resonance 
saturation, and Chapter 4 will discuss the development of an MRI reporter gene, magA, 
that can be used to enable cells to produce iron oxide nanoparticles capable of causing a 







Contrast in MRI 
 
 The principles of MRI follow from the same principle of exciting spins as found 
in nuclear magnetic resonance (NMR) [4, 5]. In most cases, the MRI machine is tuned to 
image the most abundant spin population found in the body, that of the protons of bulk 
water. Contrast in MRI arises from the difference in signal in adjacent pixels or voxels 
due to three basic parameters, spin density, T1, and T2 (Figure 1.1). The spin density, 
proportional to M0, reflects the total number of spins available to be imaged within a 
given tissue (or pixel). The system of spins is excited by radiofrequency (RF) energy, 
followed by a period of spatial encoding and then a period of signal acquisition during 
which the spin system is emitting energy as it relaxes to its equilibrium state. This energy 
is received as the signal for the MRI image.  
 
 The signal therefore depends not only on the spin density, but also upon two 
decay parameters, T1 and T2, which describe the rates at which the spin system is 
changing. T1 is rate at which the system returns to equilibrium following excitation by 
RF energy. The faster the system returns to equilibrium, the more spins available to be 
excited by the next imaging pulse. The effect of T1 on the signal is indicated in Figure 
1.1b. For a given amount of time, a pixel with a shorter T1 would result in greater signal.  
 
 T2, often called spin-spin relaxation, refers to decay time of the signal received. 
During signal acquisition, the effect of field inhomogeneity, mostly arising from nearby 
spins affecting each other, causes the coherence of the signal to be lost. This decay rate is 
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indicated in Figure 1.1c where, for a given amount of time, a pixel with a shorter T2 
would result in less signal compared to an identical pixel in which all other parameters 







Figure 1.1: Three basic parameters of MRI. a) The spin density, proportional to 
M0, is related to the net amount of spins aligned along the main magnetic field, b) 
a T1 curve indicating that shorter T1 times result in a quicker return to the 
equilibrium state, resulting in a greater magnetization available for imaging, c) a 
T2 curve indicating that shorter T2 times result in a quicker loss of signal in the 













−∝       (1.1) 
 
 Here, TR is the repetition time and TE is the echo time of the imaging pulse 
sequence. This equation represents the effects described above. The signal (S) is 
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proportional to spin density (M0). It is increased by a shorter T1 and decreased by a 
shorter T2. By choosing TR and TE carefully, images can be chosen to favor T1, T2 or 
spin density weighting. Table 1.1 shows the decay rates of several tissues at 1.5T and 
37°C. The well-known utility of MRI in imaging soft tissue arises from the natural 
differences in decay rates of various tissues, as in the case of brain imaging where gray 
and white matter can be easily distinguished. Figure 1.2 shows some examples of the 





Table 1.1: Typical decay rates for tissues at 1.5T and 37°C. R1≡1/T1, 
R2≡1/T2. (data from ref. [5]) 
 
Tissue T1 (ms) R1 (s-1) T2 (ms) R2 (s-1) 
gray matter 950 1.05 100 10 
white matter 600 1.67 80 12.5 
Muscle 900 1.11 50 20 
cerebrospinal 
fluid (CSF) 4500 0.22 2200 0.45 
Fat 250 4.00 60 16.67 






Figure 1.2: Examples of images obtained with different MRI weighting 
approaches. Spin density images show brighter pixels in correlation with 
increased presence of spins. T1 weighting, brings out differences in white and 
grey matter (see T1 times in Table 1.1) where white matter, with the shorter T1, 
appears brighter. T2 weighting allows fluids, such as cerebrospinal fluid, to 






 Since these are the basic parameters of contrast in the MR image, it is these 
parameters that should be altered by any potential contrast agent. The most common MR 
contrast agents are paramagnetic gadolinium ion complexes and superparamagnetic iron 
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oxide particles (see Table 1.2). Gadolinium contrast agents are used primarily for their 
ability to shorten T1, although at high concentrations, they can have significant effects on 
T2 as well. Iron oxide agents, on the other hand, have less effect on T1 and are used 
primarily for their effect on T2. Based on equation 1.1, it can be seen that gadolinium 
enhanced T1 imaging would show bright pixels in locations where contrast is present, 
and iron oxide enhanced T2 imaging would show decreased signal where contrast agent 
is present. In either case, it is the contrast with adjacent pixels that is the desirable effect. 
 
 In practice today, these contrast agents are non-specific. They are taken up into 
tissues based on passive biodistribution. Oral agents are useful for picturing bowel, and 
organs that filter the blood such as the liver and kidneys, have high concentrations of 
contrast when agents are injected intravenously. In order to extend the use of contrast 
agents to other, specific tissues, it is necessary to develop targeted probes. Such probes 
have the advantage of targeting and delineating areas of specific molecular activity on an 
MR image. For instance, in clinical procedures, an anatomical image revealing a mass 
would be routinely biopsied. If, however, there were a way to deliver a contrast agent that 
is only activated under specific, controlled circumstances, such as the expression of a 
carcinogenic genotype, one could obtain an image that provides molecular, as well as 
anatomical information. The need for biopsy would be reduced. This example represents 
a great advancement in clinical diagnosis, yet it represents a relatively modest goal of the 






Table 1.2: Relaxivity values of common contrast agents. Gadolinium-based 
agents are generally used for their ability to shorten T1, while iron oxide based 
agents are generally used for their effect on T2. (data from ref. [6]) 
 
MR Contrast Agent Main use 
Molecular 




(mM s)-1 Target 
Gd-DTPA T1-agent 0.6 kDa r1= 3.7 Extracellular 
Dextran-Gd-DTPA T1-agent 75 kDa r1= 11 Blood-pool 
Carboxydextran-
coated SPIO SHU-555 
T2-
agent 62 nm 
r1= 12 






agent 58 nm 
r1=24 















agent 17-20 nm 
r1=23 
















agent 40 nm 
r1= 3 






agent 12 nm 
r1= 8 





 Targeted imaging applications raise the need for development of new contrast 
agents capable of being detected at low concentrations. Successful in vivo imaging with 
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MRI often requires target concentrations on the order of 10 µM [2]. In these applications, 
the contrast agent molecule is conjugated to the ligand which will bind the target, 
meaning the contrast agents must be effective at micromolar concentrations. The ability 
to use gadolinium for molecular imaging applications is therefore limited by its need to 
be present in millimolar quantities in order to cause a visible contrast. In Table 1.2, it can 
be seen that the r1 of gadolinium agents is on the order of tens of mM-1 s-1  (3.7-11 mM-1 
s-1), whereas for superparamagnetic iron oxide nanoparticles (SPIO), the r2 is larger, on 
the order one to two hundred mM-1 s-1. The effect of SPIO nanoparticles is further 
magnified by the fact that these values are cited for mM Fe, but each nanoparticle 
contains several thousand iron atoms. Therefore, the relaxivity per particle is amplified 
by this factor, allowing SPIO to be an effective contrast agent even when molecular 
targets are present at low, micromolar concentrations.  
 













 Molecular imaging, in general, refers to the study of cellular and molecular events 
through noninvasive investigation [1]. In MRI, molecular imaging is dependent on 
induced changes in proton relaxivity on the molecular and cellular level. Bringing 
molecular imaging to human MRI requires generating contrast on the molecular level that 
is not only specific, but also sensitive enough to be observed at the voxel level. MRI 
scanners at 3 Tesla, the current state of the art in human clinical scanning, offer 
submillimeter resolution. Although this resolution provides for detailed anatomical 
pictures, it presents challenges for molecular imaging. Probes must be able to generate 
contrast by specific molecular mechanisms, yet the change in signal must be large enough 
to be visible on the voxel level. 
 
 Over the last decade, biocompatible iron oxide particles have been linked to 
specific ligands for targeted molecular imaging applications [7-11]. However, due to their 
relatively large size and clearance by the reticuloendothelial system (RES), there is still a 
lack of widespread biomedical molecular application. Imaging of macrophage activity 
remains the most significant application, particularly for tumor staging of the liver and 
lymph nodes, and several commercial products are either approved or in clinical trials. 
Labeling non-phagocytic cells in culture using modified particles, followed by 
transplantation or transfusion in living organisms, has led to an active research interest to 
monitor cellular biodistribution in vivo, including cell migration and trafficking. While 
most of these studies have been more focused on establishing techniques, further use of 
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these approaches will be as tools to obtain deeper insights into the dynamics of in vivo 
cell biology and at monitoring therapies that are based on the use of stem cells and 
progenitors. 
 
 In order to tackle the various aspects of this problem, this work is divided into 
three main goals in developing a molecular imaging approach for MRI: 
 
 
Elucidation of the contribution of size and coating properties to magnetic nanoparticle 
induced proton relaxation. 
 
In order to maximize the contrast generated from magnetic nanoparticles without 
increasing their size, new methods to increase their effect on relaxivity must be 
developed. Experimental data obtained on a new class of biocompatible particles are 
presented, along with simulated data. The effects on relaxivity of coating size, proton 
exchange, and altered diffusion are examined with the goal of increasing proton 
relaxivity so that maximum contrast can be generated from small particles without 
increasing core size.  
 
An important feature of targeted contrast agents for MRI is a controllable 
switching mechanism in which contrast agents are “activated” by a specific molecular 
interaction. In MRI, clustering of particles can have a significant effect on relaxivity [12]. 
The clusters must alter the MR signal in a way that is identifiable against a background of 
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unclustered particles. Simulations are presented showing the influence of particle 
coatings on clustering-induced relaxivity changes, and an experimental system 
demonstrating the clustering effect is presented. This work helps to advance this concept 
by exploring ways to maximize the effect of clustering on the MR signal. This ensures 





Development of a diffusion-dependent, off-resonance imaging protocol for magnetic 
nanoparticles. 
 
Currently, superparamagnetic contrast agents are used for their effect on T2 or 
T2*. This results in a negative contrast, or a darkening in the resulting the image. Signal 
voids, however, can be caused for many reasons including field inhomogeneities and 
susceptibility-induced artifacts such as those at tissue interfaces. These issues make 
identification of positively labeled cells inconclusive. At high main magnetic field 
strengths, which are becoming clinical standards, the sensitivity to susceptibility-induced 
artifacts from such macroscopic field inhomogeneities is increased. Because the particles 
cause local field inhomogeneities, it is possible, by applying off-resonance irradiation, to 
exploit the effect of field inhomogeneity as an alternative contrast mechanism for these 
agents. 
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This work demonstrates an alternative approach, termed off-resonance saturation 
(ORS), for generating contrast sensitive to SPIO nanoparticles. This method leads to a 
calculated contrast that increases with SPIO concentration. Experimental data 
demonstrate that in the presence of these particles, an off-resonance effect exists, that is 
distinct from the magnetization transfer (MT) effect, and is highly dependent on 
diffusion. Data show that the dependence on water diffusion becomes most significant at 
rates of 0.5 × 10-9 m2/s and slower. The dependence of the off-resonance effect on off-
resonance frequency and particle concentration are also investigated. The data suggest a 
useful frequency offset range of 500 Hz < |∆ω| < 1500 Hz at 3T. This approach may be 




Development of a genetic MRI marker via in vivo magnetic nanoparticle synthesis  
 
One major application SPIO nanoparticles is the in vivo tracking of cells, where 
cells are labeled in culture using modified particles, followed by transplantation or 
transfusion in living organisms. A limitation of this approach is the need to label cells in 
vitro with pre-synthesized nanoparticles prior to cell transplant. As a result, particle 
concentration within cells decreases over time as the cells grow, migrate, and divide, and 
particles cannot be readily linked directly to in vivo gene expression. One way to 
overcome this is to utilize a genetic approach. Green fluorescent protein (GFP) is perhaps 
the most well-known genetic marker for optical imaging.  
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This work seeks to provide a gene expression marker for MRI based on bacterial 
magnetosomes, tiny magnets produced by naturally occurring magnetotactic bacteria. 
Here, magA is expressed in a commonly used human cell line, 293FT, resulting in the 
production of magnetic, iron oxide nanoparticles by these cells. MRI shows that these 
particles can be formed in vivo utilizing endogenous iron and can be used to visualize 
cells positive for magA. These results demonstrate that magA alone is sufficient to 
produce magnetic nanoparticles and that it is an appropriate candidate for an MRI 




RELAXATION BY MAGNETIC NANOPARTICLES 
 
 
Background and Significance 
 
 The coupling of proton spins with larger magnetic moments increases the 
relaxivity of water making them useful as contrast agents for MRI. In the presence of 
paramagnetic substances, such as iron oxide nanoparticles, water relaxation time 
constants, T1, T2 and T2*, of proton nuclear spins are shortened [5]. With regard to T2 
and T2*, magnetic nanoparticles act as magnetic moments producing tiny field gradients 
through which protons diffuse. As each proton will take a separate path through the field 
gradients, phase differences among protons will accumulate. The result is a 
susceptibility-induced dephasing of the MR proton signal and a subsequent reduction in 
T2. This T2 shortening can be utilized in an imaging experiment when the nanoparticles 
are strongly magnetized. In this condition, τ∆ωr>1, where τ is half the echo time for a 
single Hahn spin-echo sequence (τ = TE/2) or half the interval between 180˚ pulses in a 
Carr-Purcell-Meiboom-Gill (CPMG) [13] sequence and ∆ωr is the root-mean-square 
angular frequency shift at the particle surface. The work here is limited to spherical 
particles. 
 
 The most common MR contrast agents are paramagnetic gadolinium ion 
complexes and superparamagnetic iron oxide particles. Relaxation is caused by a time-
15 
modulated interaction between the protons and the magnetic moment [4]. Coupling may 
be of dipolar and scalar nature, while time modulation arises from translational diffusion 
of the protons, rotational diffusion of the magnetic compound, and exchange of protons 
between binding sites and free water. 
  
 Currently, theories predicting T2 shortening by paramagnetic ions magnetic 
nanoparticles can be divided into two groups: inner sphere (IS) and outer sphere (OS) 
models [14]. Inner sphere theory accounts for the exchange between coordinated water 
molecules and bulk water. Outer sphere theory describes the relaxation induced by the 
diffusion of water molecules within the magnetic field gradients around the paramagnetic 
hydrated ion. The IS contribution consists of protons physically interacting with the 
paramagnetic ion. In this scenario, the distance between the ion and the coordinated water 
molecule is on an average smaller than that between the hydrated ion and a diffusing 
water molecule in the OS model. Additionally, coordinated protons reside on the binding 
site longer, exposing them to the magnetic ion for a longer time than in the case of the 
diffusing proton in the OS model. As a result, the IS contribution is generally larger than 
that of OS. However, for chelated ions and in the absence of water exchange, the OS 
mechanism dominates relaxation. 
 
 Relaxation induced by magnetite (Fe3O4) particles is generally attributed to the 
diffusion of water molecules around the superparamagnetic iron core. It can be generally 
described by an OS theory adapted to account for the anisotropy of magnetite crystals 
[15, 16]. The application of IS versus OS theories can be mathematically determined by 
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the criterion τD∆ωr, where τD = r2/D (r is the particles radius, D is the water diffusion 
coefficient, and ωr is the rms angular frequency shift at the particle surface). For 
τD∆ωr<1, a motional-averaging regime is satisfied. The relaxation rate is then given by 
quantum-mechanical outer sphere theory:  
 
2
2 )()9/4(/1 rDvT ωτ ∆=   (2.1) 
 
where v is the volume fraction occupied by the nanoparticles. For τD∆ωr>1, a static 
dephasing regime is employed. This term refers to the dephasing of motionless magnetic 
moments but remains valid for slow motion where the dephasing experienced in a single 
encounter of proton and field shift amounts to larger than one radian. In this case, the 
relaxation rate for spherical particles is characterized by the equation: 
 
9/15/1 *2 rvT ωπ ∆=   (2.2) 
 






4 3 MrBeqr γπγµγω ===∆   (2.3) 
 
  
where γ is the proton gyromagnetic ratio, Beq the equatorial magnetic field of the particle, 
µ the magnetic moment, and M its magnetization. In the case of synthetic iron oxide 
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nanoparticles, it is likely that a combination of processes occurs in the dephasing process. 
In a well-dispersed solution, protons will diffuse through magnetic gradients, 
accumulating a phase by ∆ω = γ∆B, where B is the magnetic field experienced by the 
proton due to the particle. However, at the interface between particle and water protons, it 
is likely that several types of events occur. Protons may physically exchange with protons 
in the molecules comprising the particle coating. Such interactions are generally known 
as chemical exchanges and have been utilized for imaging using magnetization transfer 
contrast (MTC) [17, 18] and in developing a class of compounds known as chemical 
exchange dependent saturation transfer (CEST) agents [19].  
 
 It is possible, however, that coating molecules may influence protons in ways 
other than direct chemical exchange. Proton diffusion may be slowed in regions near the 
particles due to molecular forces and in some cases, such as those of PEG-coated 
particles, it is possible that protons could diffuse in and out spaces between coating 
molecules (Figure 2.1). The result could be an effective alteration in proton diffusion 
around the particles resulting in a change in the nanoparticles relaxation characteristics 








Figure 2.1: Various schemes of proton diffusion and interaction with 
nanoparticles and their coatings. a) diffusion of protons past the nanoparticle 
represent the dominant contribution in outer sphere (OS) theory, b) diffusing 
water protons may exchange with protons on the particle surface; the increased 
residence time and close proximity result in the inner sphere (IS) effect, c) 
diffusion may be restricted by the particle coating resulting in a scenario 




 Present theories focus on either diffusion past a particle or chemical exchange as 
mechanisms for relaxation. Interaction between protons and nanoparticle coatings are not 
well understood, however, and could have significant influence on induced relaxation. 
Such interactions are not fully accounted for in present theories, and a further 
understanding of such influences can aid in developing more effective probes. This is 
especially important in in vivo imaging where maintaining small probe size is important 




 Superparamagnetic iron oxide nanoparticles are increasingly used in the 
development of MRI probes because of their effect on relaxivity [20]. These 
nanoparticles are already used regularly for applications such as high-density magnetic 
storage, catalytic and separation processes [21], and they are now playing an expanding 
role in vivo tracking of stem cells and tumor progression [22, 23], cell and DNA sorting 
[24], drug delivery [25] and cell mechanics studies [26].  
 
 Currently, the most common iron oxide nanoparticles for MRI are 
monocrystalline iron oxide nanoparticles (MION) that contain core crystals (4.6 nm 
diameter) of iron oxide generated in a solution of dextran. The resulting particles are 
soluble because of this dextran coating but have hydrodynamic diameter of 20-40 nm. 
Cross-linked iron oxide (CLIO) nanoparticles [27] have been developed as well for use in 
functionalizing the surface coating. The physiochemical properties of MION are well 
known [28, 29], and the surface properties of dextran-coated particles have been studied 
extensively [30, 31]. However, because the particles are generated at the same time the 
coatings are formed, there is little control over specific coating characteristics at the 
synthesis step. This makes these particles difficult to use in studies of proton relaxation 
effects since coating properties such as thickness and surface composition are difficult to 
alter. Therefore, it is desirable to develop particles in which the coating is formed in a 





Studies of a polyethylene-glycol coated magnetic nanoparticle 
 
 A variety of in situ and post-synthesis coating strategies have been developed for 
stabilization of magnetic nanoparticles. Post-synthesis coating processes include using 
monolayer ligand [32, 33], polymer [34, 35] and silica coatings [36-38]. The monolayer 
ligand coatings rely on effective adsorption or chemisorption of the ligand on the surface 
of the nanoparticle. These coatings tend to have limited colloidal stability, limited 
flexibility for functionalization, and the tendency to form incomplete coatings due to 
residual surfactant on the surface. The polymer- and silica-based coating processes are 
difficult to control, often resulting in multilayered coatings and multiple nanoparticles in 
the same encapsulation [37]. In situ coating approaches such as that with dextran [39] 
often lead to multilayered coatings, which can result in a heterogeneous size distribution. 
This can make quantification of clustering effects on relaxation unreliable. In situ 
synthesis conditions also limit the variety of functionalization methods that can be 
achieved. 
 
 In preparation for the long-term application of molecular imaging probes, 
experiments were conducted to produce particles with appropriate characteristics for in 
vivo delivery. One challenge of this application is to develop magnetic nanoparticle 
probes with a size comparable to the target proteins and nucleic acids (~2-15 nm). To 
facilitate cellular delivery and specific intracellular targeting, these particles need both a 
probe portion and targeting ligands on their surface. Such probes can then be used to 
generate an intracellular MRI contrast for cell tracking purposes. More sophisticated 
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probes can be designed to generate contrast based on molecular specificity through 
clustering of magnetic nanoparticles or other molecular switch mechanisms [40].  A 
critical step in developing such molecular probes is to functionalize the nanoparticles 
with a biocompatible coating. 
 
 In collaboration with Dr. Gang Bao (Dept. of Biomedical Engineering, Georgia 
Tech), functionalized magnetic nanoparticles for intracellular delivery were developed 
and tested for relaxation characteristics [41]. Specific coating and experimental protocols 
for the design and synthesis of these particles were developed by Drs. Gang Bao, Leslie 
LaConte and Nitin Nitin in this collaboration. These particles are water-soluble, 
monodispersed, biocompatible, and easily adaptable for multifunctional bioconjugation 
of probes and ligands.  In this approach, superparamagnetic monocrystalline iron oxide 
nanoparticles (MIONs) are encapsulated in a PEG-modified phospholipid micelle 
structure.  Similar encapsulation strategies have been used for various hydrophobic drug 
molecules and more recently, quantum dots [42]. The key principle of this coating 
procedure is to exploit the hydrophobic nature of the nanoparticle surface, which arises 
from residual synthesis surfactant. The hydrophobic portion of an amphiphilic structure 
such as the PEG-phospholipid used here interacts with the nanoparticle surface to create 
micelles, resulting in a self-assembled monolayer coating on the nanoparticle surface. 
The PEG portion of the molecule allows the MIONs to be soluble and biocompatible. 
The use of modified PEG molecules allows for bioconjugation [43] of protein or nucleic 
acid probes and multiple ligands. The magnetic iron oxide (Fe3O4) nanoparticle (MIONs) 
cores were provided by Dr. Charles O’Connor (University of New Orleans) and had an 
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average size of 6.6 nm with a size distribution of 11%, as determined by transmission 
electron microscopy. Specific coating protocols are described in [41]. 
 
 Dynamic light scattering (DLS) was used to determine the size of the micelle-
coated MIONs (mMIONs) using a DynaPro-LSR instrument (Protein Solutions, England) 
(Figure 2.2a). The average hydrodynamic radius of the mMIONs was 7.34 nm ± 0.71 nm 
(93.9% of mass). The size distribution as a function of % mass is shown in Figure 2.2a 
and is in agreement with results obtained by [42] for micelle-encapsulated quantum dots. 
DLS results also indicate a narrow range of polydispersity in mMIONs. The precise size 
range may provide a crucial advantage for imaging applications based on clustering of 
magnetic nanoparticles, as discussed below.  
 
 Electron microscopy was performed (Figure 2.2b) to verify the presence of 
coating and size of resultant particles. Negative staining revealed a dark iron core with an 
unstained micelle coating around the MIONs. The diameter of mMIONs as determined 
by this method is 12-14 nm, similar to results obtained by DLS. Some fraction of 
micelles without iron cores were also observed in the EM images and ultracentrifugation 
may be useful in the future to separate empty micelles from mMIONs. To determine 
concentration of Fe, a colorimetric assay using o-phenanthroline was carried out and Fe 




Figure 2.2: Characterization of mMIONs. a) Particle size distribution [% mass 
vs. hydrodynamic radius (nm) of particles] of mMIONs measured using dynamic 
light scattering.  93.9% of the sample mass has a hydrodynamic radius of 7.34 
nm.  b)  Electron micrograph of negatively stained mMIONs at a magnification of 
60,000 x.  Dark iron cores can be seen encircled by unstained micellar coating 
against the stained carbon grid background. (With kind permission of Springer 




 A 0.47 T Bruker Minispec Analyzer MQ20 was used for T2 measurements. 
MDBK cells (derived from bovine kidney) were grown in culture and incubated with 
mMIONs and media. After incubation, cells were washed with PBS to remove 
extracellular and unbound mMIONs. Cells were collected in a final volume of 1.5 ml of 
media. 500 µl of this cell suspension were placed in a 10 mm sample tube for T2 
measurements using the CPMG pulse sequence [13]. Images of cell samples were 
obtained on a 3T Siemens TRIO MRI system using a T2-weighted Turbo Spin Echo 
sequence. 
 
 Here, phospholipid-PEGs are modified with commercially available functional 
groups such as amines and sulfhydryls. These can be easily incorporated into micelles to 
coat MIONs. This provides flexibility in functionalizing the nanoparticles. To 
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demonstrate the ability of mMIONs to generate intracellular contrast, they were 
bioconjugated with the HIV Tat peptide via a reactive amine group to the surface of 
mMIONs for delivery into cells. The Tat peptide is known to direct intra-cellular delivery 
of proteins, nanoparticles, and other macromolecules [12, 44]. 
 
 T2 relaxation times and MR images were obtained to validate the delivery of 
mMIONs into live MDBK cells. For T2 measurements, MDBK cells were incubated with 
Tat-mMIONs for 1 hour and then washed to remove extracellular and unbound mMIONs. 
A suspension of this preparation was used for T2 measurements. The T2 determined for 
cells with mMIONs was 623 ± 2 ms, and that for control cells without mMIONS, the T2 
was 1503 ± 20 ms (see Figure 2.3a). In the mMION-treated cells, the T2 time is at least 
two times shorter than control cells, indicating internalization of magnetic nanoparticles. 
The shortened T2 time of cells with mMIONs can be visualized when imaged using a 
clinical MR system (Figure 2.3b), again indicating the presence of the contrast agent 
inside cells. 
 
 In future work, a variety of targeting mechanisms may be employed. Because 
their size is on the order of many intracellular biomolecules, including proteins and 
nucleic acid-protein complexes, these mMIONs may be suited for probing intracellular 
events with less interference than other currently used iron oxide-based molecular probes. 
The small diameter and uniform size distribution are also desirable for future work in 
clustering techniques. This work is a first step towards the development of more powerful 







Figure 2.3: The effect of mMIONs on water relaxation inside living cells. a) 
T2 relaxation time (ms) measurements obtained using Bruker MQ20 Minispec. 
MDBK cells with mMIONs gave a T2 relaxation time of 604 ± 37 ms, while cells 
without mMIONs had a T2 time of 1473 ± 75 ms. b) MRI images of four different 
samples: (1) culture media only, (2) cells without mMIONs, (3) cells with 
mMIONs, (4) culture media only. Images were obtained using a 3T Siemens 
TRIO, turbo spin-echo, TR 4000, TE 310, in-plane pixel size 0.5 × 0.5 mm. (With 










Effect of Particle Size Variation on Transverse Relaxivity 
 
Background 
 There are many factors that could potentially affect the ability of the magnetic 
nanoparticle to induce T2 shortening. These include physical size of the particle and its 
coating, chemical properties of the coating and surrounding environment, motion of 
particles and protons, and inhomogeneities in the particles themselves. By adjusting the 
core size, coating thickness, surface chemistry, and targeting ligands, nanoparticle probes 
have been tailored to target specific organs, cells, or even molecular markers of different 
diseases in vivo [20, 45].  The relaxivity of magnetic nanoparticles has typically been 
modulated by their core size, often in the range of 4-20 nm in diameter [45]. There is, 
however, less known about the effect of coating properties on relaxivity induced by the 
nanoparticles. Because many of these factors can interact in complicated ways to affect 
relaxivity, elucidating the effect of coating properties on T2 shortening can provide a 
useful basis for the development of more powerful nanoparticle probes without the need 
for increasing probe size. 
 
 For a spherical particle of a particular core size, one can imagine field lines are 
distributed through space according to the dipole equation (Figure 2.4a). Here we are 
only concerned with the z-component of the field. Magnetic nanoparticles induce T2 
relaxation as protons pass through these field gradients. The protons individually 
accumulate phase changes according to φ=γ·Bz·∆t where ∆t is the amount of time the 
proton spends in a field gradient. Since protons are initially in phase, the signal decay, 
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due to dephasing, occurs due to the field gradients of the particle and not the main 
magnetic field. In Figure 2.4a, a particle core (green) is producing a certain magnetic 
field through which particles may diffuse. In Figure 2.4b, the same core is surrounded by 
a coating, which physically excludes diffusing protons from some area around the core. 
Although the core produces the same field, protons have less access to the higher 
gradients near the particle. As a result, it is predicted that proton relaxation in the coated 








Figure 2.4: Particle coatings prevent protons from approaching the 
magnetic core. a) Protons diffuse through the dipole field of the nanoparticle in 
green. b) Due to a large coating (blue), protons cannot access space nearest the 





 In most of the studies involving MIONs [32, 36, 38, 39, 46], it is not possible to 
independently alter the coating size without a significant change in the chemistry of the 
surface coating. In addition, with some of the existing coating methods, it is very difficult 
to obtain a narrow size distribution of coated particles. The variations in the overall size 
of coated particle can limit an independent analysis of the role of size and chemistry of 
coatings on relaxivity characteristics of MIONs, making it difficult to gain a fundamental 
understanding of the magnetic relaxation processes involved in contrast generation by 
MIONs.   
 
 In this study, micelle-based phospholipid-polyethylene glycol (PEG) coatings 
were used to encapsulate MIONs as described previously [41]. This coating allows 
control of coating thickness by simply varying the length of the PEG polymer that is on 
the outermost surface of the particles, while keeping both the chemical composition of 
the coating itself and the size of the core iron oxide nanoparticle constant. This allows an 
independent investigation of the contributions from coating thickness on the effective 
magnetic relaxivities of MIONs.  A set of mMIONs were prepared (courtesy of Leslie 
LaConte and Nitin Nitin, Georgia Tech) with phospholipid-PEG conjugates of increasing 
molecular weights (PEG 550, PEG 750, PEG 1000, PEG 2000, and PEG 5000) which 
yield a corresponding increase in coating layer thickness as demonstrated by dynamic 




 To gain a more complete understanding of these effects on relaxation, a computer 
simulation was developed to predict how coating characteristics affect relaxivity.  
Simulations were carried out with two models. One assumes that the coating is 
impermeable to water and the other assumes that water has a slower diffusion constant 
when in contact with the outer layer of the phospholipid-PEG coating as compared to 
bulk water.  When taken together, the experimental and simulated results contribute to an 
understanding of the relationship between coating thickness and changes in relaxivity and 
can provide important guidelines for the optimal design of magnetic nanoparticle probes 





Coating of Magnetic Nanoparticles 
 Monocrystalline iron oxide (Fe3O4) nanoparticles (MIONs) were dispersed in 
toluene and insoluble in water prior to modification.  PEG-encapsulated particles were 
prepared as before with the caveat that each preparation was made with one of five 
different phospholipid-PEG conjugates (Avanti Polar Lipids, Huntsville, AL).  They each 
had the formula, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
methoxy(polyethylene glycol) X (DSPE-mPEG X), where X represents the molecular 
weight of the PEG portion of the lipid-PEG conjugate.  PEG molecular weights (X) used 
in these experiments were 550, 750, 1000, 2000, and 5000.  DSPE-mPEG X (in 
chloroform) was mixed with MIONs (50 µl of 3.3 mg/mL stock solution) and further 
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diluted with 3 mL of chloroform.  This mixture was subsequently placed in a rotary 
evaporator with water bath temperature set to 60°C and left under vacuum (10 mTorr) for 
30 minutes to remove all traces of organic solvents.  The dried film was resuspended in 
500 µl deionized water with agitation and sonication.  The solution obtained was filtered 
using 0.1 µm Anotop inorganic membrane syringe filters (Whatman International Ltd., 





 Dynamic light scattering (DLS) using a Particle Sizing Systems-NICOMP 
380ZLS, which allows specific measurement of the hydrodynamic radius of 
macromolecules in the size range of 1 nm-1 µm was used to determine the size of the 
micelle-coated MIONs (mMIONs).  500 µL of mMIONs were filtered using Anotop 0.1 
µm inorganic membrane syringe filters (Whatman International), transferred into a 1 mL 
disposable glass tube, and spun at 10,000 g for 1 minute prior to DLS measurements.  
DLS scattering data was collected at room temperature for 1 hour.  The number-weighted 
NICOMP analysis was used to obtain approximate hydrodynamic radii and population 
distributions for each sample. 
 
 To further determine the size of the mMIONs, transmission electron microscopy 
(TEM) was performed.  Approximately 5 µL of mMION solution was placed on a carbon 
grid.  5 µL of 1% phosphotungstic acid was added and allowed to sit for 30 seconds for 
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negative staining.  Liquid was then removed from the carbon grid, and the grid was 
imaged on a Hitachi H-7500 transmission electron microscope.  Scanned images were 




 A 0.47 T Bruker Minispec Analyzer MQ20 was used for T1 and T2 
measurements.  500 µL of each sample (diluted from stock solution in phosphate buffered 
saline from Sigma, St. Louis, MO, pH 7.4 (PBS)) were placed in a 10 mm sample tube 
and allowed to equilibrate to 20°C in a circulating water bath.  All the measurements 
were made at 20°C using a temperature-controlled probe cavity with an external water 
bath.  Each measurement was repeated three times to measure variations within the 
readings. T2 curves were obtained using the Carr–Purcell–Meiboom–Gill (CPMG) pulse 
sequence and T1 values were obtained using an inversion recovery pulse sequence.  T2 
curves were fit to a monoexponential decay equation using CFTOOL in Matlab 7.0.  
Relaxivities (mM-1·s-1) were calculated by taking the inverse of T1 and T2 times (s) and 
normalizing these values by the iron concentration (mM) for each sample as determined 
by the o-phenanthroline reaction [41]. Each relaxation measurement for a given coating 






pH Variation Measurements 
 pH was varied by using a sodium phosphate buffer composed of monosodium 
phosphate, monohydrate (Sigma) and disodium phosphate heptahydrate (Aldrich) 




 Monte Carlo simulations of proton random walks have been used previously to 
estimate transverse relaxation induced by diffusion through inhomogeneous magnetic 
fields [47-50]. For this simulation, protons take random walks through a three-
dimensional space containing fields representing iron oxide nanoparticles. In the 
simulation, protons accumulate phase changes as they diffuse through the fields created 
by these magnetic dipole moments. The normalized signal is computed from N different 











)(1)( ϕ     (2.4) 
 
 Here φn(t) is the phase of the nth proton at time, t. The simulation proceeds as 
follows. Particles are randomly distributed in space. A sufficiently large space is chosen 
to eliminate edge effects. Protons take random walks through the particle fields. At each 
time step, the sum of Bz due to the particle dipolar fields is computed and the proton 
accumulates phase according to φ=γ·BZ·∆t (with γ the gyromagnetic ratio and ∆t, the 
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time step). Simulations are performed with N protons, typically between five hundred and 
five thousand. Magnetic parameters used are chosen individually to be representative of 
the experimentally characterized particles. For instance, for MION 46-L particles [28], 
parameters are 2064 Fe atoms per particle, 65 emu/g Fe, average diameter 4.6 nm.  
 
 Phase changes are accumulated in regular intervals and R2 and R2* are calculated 
as follows. First, to calculate T2*, a decay curve is constructed. For each proton, the sum 
of phase up to each time point is calculated for that time point. Using equation 2.4, the 
signal for the time point can then be calculated. In order to calculate T2, a spin-echo is 
formed. For a given time-point, the phase change accumulated during the second half of 
the echo time is subtracted from the phase accumulated during the first half of the echo 
time. This simulates the effect of the 180° pulse in the spin-echo sequence. The decay 
curves used for T2* do not involve this subtraction and are analogous to the free 
induction decay. Figure 2.5 shows a typical decay curve. The decay constant, T2 or T2* 









Figure 2.5: Standard decay curve showing both simulated data and fitted 
decay equation, exp(-t/T2) or exp(-t/T2*) . The relaxivities, R2 and R2* were 
found to be the same for given simulation parameters. This is expected for the 





 Unlike previous simulations in which large time-steps on the order of 200 µs were 
used [47], here, a short time step of 1 ns was chosen to ensure its length was not 
artificially influencing simulation results.  The time step was progressively shortened 
(down to 0.5 ns) until no effect was observed. Results were equivalent at 0.5 ns and 1 ns 
and thus the time step was set to 1 ns to reduce computation time.  Simulations were 
performed using 500 protons, and magnetic parameters used were representative of 
nanoparticles with a 6.6 nm core diameter (6070 Fe atoms per particle). Phase changes 
were accumulated in 50 µs intervals.  An additional parameter, exclusion radius, was 
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introduced as a spherically-shaped, excluded space into which protons were not allowed 
to diffuse, thus effectively controlling the minimal distance of approach for protons in 
solution. Simulations were performed varying exclusion radius from 4.5 to 50 nm to 
mimic variation in the thickness of the micelle coating.   
 
 In order to simulate slow/restricted diffusion, the model was further refined to 
include a coating layer in which the water diffusion coefficient was slower (2.5 × 10-10 
m2/s) than bulk water (2.5 × 10-9 m2/s).  The thickness of this layer was then varied from 




Results and Discussion 
 
Size Determination by DLS and EM 
 The sizes determined by DLS and TEM are listed in Table 2.1. The results show 
the expected general trend of an increase in the particle diameter with an increase in PEG 






Table 2.1: Variation of diameter of coated mMIONs. Changes in coating size 
were determined by DLS, EM, and from Ref. [51]. (Reprinted with permission 
from ref [52].) 
 
Coating Type Hydrodynamic 




Diameter (nm) (Ref. 
[51]) 
DSPE-PEG-550 12.5±1.3 10.96 ± 1.9 Not determined 
DSPE-PEG-750 10.35±2.6 13.63 ± 1.3 10.2 
DSPE-PEG-1000 12.0±0.8  13.23 ± 1.1 Not determined 
DSPE-PEG-2000 16.4±3.1 14.6 ± 0.34 13.4 





 DLS results show no significant difference in the hydrodynamic diameter of 
DSPE-PEG 550 and 750, possibly due to the low resolution of the DLS technique at this 
size range.  The EM data show no significant difference between the diameters of DSPE-
PEG 750 and DSPE-PEG 1000, likely due to difficulties in estimating diameters from the 
negatively stained images and only a small difference in polymer length when the 
particles are dried on carbon grids.  It is expected that the particle hydrodynamic diameter 
would be larger than the dry particle diameter determined by EM, due to counterions or 
water itself forming a diffuse layer that moves with the mMION [53].  This is indeed the 
case with the larger diameter samples (DSPE-PEG 2000 and DSPE-PEG 5000) due to the 
fact that the negative staining technique and imaging conditions in EM do not preserve 
the extended structure seen in a hydrated sample in solution. These diameter data are in 
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general agreement with the hydrodynamic diameters of DSPE-PEG micelles previously 
reported [51].   
 
 
Effect of Coating Thickness on r1 and r2 Relaxivities of mMIONs 
 The results for r2 relaxivity as a function of DSPE-PEG size (PEG 550, 750, 





Figure 2.6: Effect of coating thickness on r2.  Measurement of r2 for mMIONs 
with coatings with different DSPE-PEG size (PEG 550, 750, 1000, 2000 and 
5000) indicates that r2 decreases as the molecular weight of the PEG portion of 




 These results indicate that the r2 value decreases as the size of the DSPE-PEG 
polymer, and thus the mMION diameter (see Table 2.1), increases.  As seen in the plot, 
there is a significant (almost 2-fold) increase in the r2 with the decrease in coating size 
from DSPE-PEG 5000 to DSPE-PEG 550.  However, for the polymer sizes ranging from 
PEG 1000 to PEG 5000, there was no significant change in the relaxivity value (194 ± 57 
mM-1s-1, 147 ± 34 mM-1s-1, and 173 ± 30 mM-1s-1, for PEG 1000, PEG 2000, and PEG 
5000, respectively). These results clearly indicate the significant role that coating size 
plays in determining the net magnetic relaxivity of mMIONs.  The highest r2 values are 
observed for the mMIONs coated with DSPE-PEG 550 and 750 (317 ± 58.8 mM-1s-1 and 
360 ± 40 mM-1s-1, respectively), which have the smallest diameters.  This indicates that 
by reducing the coating size, the negative contrast produced by mMIONs can be 
significantly increased.  This is important for medical applications, as higher contrast 
typically leads to a higher sensitivity and a reduced amount of contrast agent required for 
imaging.   
 
 Another important consideration for the effect of coating thickness on relaxivity is 
the recent trend in molecular imaging, which relies on the conjugation of targeting 
molecules to the surface of contrast agents such as mMIONs [20].  In molecular imaging, 
it is important to maximize the contrast generated by each nanoparticle probe, since target 
concentrations are often quite low (for example, on the order of 10,000 binding sites per 
cell for the atherosclerosis target VCAM-1 [54] and 10,000 folate receptors in brain 
glioma cells [55]) and in vivo binding affinities can vary greatly.  Successful in vivo 
imaging with MRI often requires target concentrations on the order of 10 µM [2].  The 
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engineering of nanoparticles with high relaxivity is thus highly advantageous for specific 
targeting of low-abundance receptors or antigens.  Furthermore, the conjugation of large 
biomolecules such as antibodies (average diameter ~10 nm) to the surface of 
nanoparticles for specific targeting may have a large effect on the r2 characteristics due to 
the increase of overall apparent thickness of the coating.  Depending on the effect of 
these biomolecules on surrounding water and its diffusion around the particle, such 
attachments may result in a decrease in the r2 of the contrast agent, thus making a thinner 





Figure 2.7: Effect of coating thickness on r1.  Measurement of r1 for mMIONs 
with coatings with different DSPE-PEG size (PEG 550, 750, 1000, 2000 and 
5000) indicates that r1 increases as the molecular weight of the PEG portion of 





 The changes in r1 as a function of PEG size are shown in Figure 2.7.  It was found 
that the r1 values increased as the molecular weight of PEG (and thus the coating 
thickness) increased. As indicated by the results in Figure 2.7, the nanoparticles with 
different coatings have two distinct ranges of r1 values: low relaxivity with DSPE-PEG 
550 and 750 (12.7 ± 3.7 mM-1s-1 and 12.6 ± 2.4 mM-1s-1) and higher relaxivity with 
thicker coatings (25.2 ± 4.9 mM-1s-1, 24.4 ± 5.88 mM-1s-1, and 21.5 ± 3.22 mM-1s-1 for 
PEG 1000, PEG 2000, and PEG 5000 respectively).  These results demonstrate that the 
size variation of the DSPE-PEG coatings also has a significant effect on r1 of the 
mMIONs, although the effect has different characteristics; as coating thickness increases, 
so does the r1.  
 
 MIONs have been predominantly used as negative contrast agents (R2 relaxivity) 
in clinical applications [45], but there has been some interest in engineering contrast 
agents with decreased R2/R1 ratios for use as blood pool agents [56, 57]. Although 
chelated Gd3+ and Gd3+-linked albumin have been the dominant blood pool contrast 
agents, they need to be used at high concentrations, have relatively short circulation 
times, and can have toxic side effects.  Therefore, the use of MIONs (or other 
superparamagnetic iron oxide nanoparticles) as blood pool agents has been explored as an 
alternative. This study indicates that it is possible to tailor the coating size to affect the 
R2/R1 ratio.  Specifically, the results shown in Figures 2.6 and 2.7 suggest that when 
coating thickness increases, the ratio of R2/R1 decreases.  Thus, the use of a thicker 
coating on MIONs may be desirable to achieve a smaller R2/R1 ratio, making these 
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nanoparticles more suitable for blood pool applications.  By modifying the coating 
chemistry in addition to the thickness, it may be possible to further optimize the R2/R1 
ratio of MIONs as blood pool agents in MR imaging.   
 
 
Effect of pH on r1 and r2 of DSPE-PEG 2000 mMIONs 
 The water relaxation processes induced by the presence of contrast agents are 
mediated by both the diffusion of protons through the magnetic field generated by each 
particle and the chemical exchange of protons with bulk water. It is likely that the 
processes involved in mMION-induced magnetic relaxation not only depend on the 
magnetic core but also on the coating layer, since the effect of the nanoparticle’s 
magnetic moment is stronger within the coating layer, because of its close proximity to 
the iron oxide core, than in the surrounding bulk water.  In addition to coating thickness, 
the specific chemistry of the coating, the packing of the coating material and the overall 
structure of the coated particle may all play a significant role in the total contrast 





Figure 2.8: Effect of pH on relaxivity.  Using buffer with different pHs (pH 5.0, 
pH 7.0, and pH 9.0) for mMIONs had no significant effect on either (a) r1 or (b) 




 Depending on the thickness and their chemical characteristics, coating materials 
may influence both the diffusion of protons and the chemical exchange processes.  
Previous studies have shown that for the case of hydrated iron oxides such as ferrihydrite 
crystals found in ferritin (iron-storing protein) and akaganeite in dextran-coated agents 
such as Fercayl, structural protons at the surface of the iron oxide play a central role in 
water relaxation because they are readily exchangeable [58].  However, magnetite does 
not have such structural protons bound at the iron oxide surface, and therefore this type of 
proton exchange has been shown previously not to dominate the observed water 
relaxation [59].  In an effort to rule out substantial contributions of chemical exchange to 
the relaxation process observed with mMIONs, the relaxivities of mMIONs at different 
pH values were measured.  Specifically, r1 and r2 were determined at three different pH 
values (pH 5.0, pH 7.0, and pH 9.0, all other conditions held constant) for a single 
coating (DSPE-PEG2000) and the results are shown in Figure 2.8.  There were no 
 43
significant differences between the relaxivities at any of the pH values, suggesting that 
the predominant factor determining water relaxation by mMIONs is the diffusion of 
protons through the magnetic field generated by each MION particle, as discussed in 
more detail below. 
 
 
Computational Simulations of the Effect of Coating Thickness on Relaxivity 
 Numerical modeling of the relaxivity of mMIONs using Monte Carlo simulation 
was performed to gain insight into the mechanisms by which coatings can alter relaxivity 
of nanoparticles.  In the simulation, protons take random walks through a field containing 
nanometer-sized magnetic inhomogeneities representing mMIONs.  Specifically, the 
mMIONs were assumed to have three regions (Figure 2.9a): (a) the Core, i.e., the iron 
oxide core that generates a magnetic field, with a closely associated hydrophobic coating 
region; (b) the layer immediately surrounding the core, composed of a portion of the 
DSPE-PEG coating that effectively excludes water, and (c) an outer layer composed of 
the PEG portion of the coating in which proton diffusion is assumed to be slower than in 
bulk water.  This model is based on a model proposed by Arleth et al. [60] for DSPE-
PEG micelles with no cargo in their core.   Based on small-angle X-ray and neutron 
scattering data, Arleth et al. [60] concluded that DSPE-PEG micelles have a hydrophobic 
core composed of the hydrocarbon chains from the phospholipids.  This core is 
surrounded first by a dense hydrophilic shell consisting of the polar headgroups of the 
DSPE and a fraction of the PEG chains and then by a loosely structured, highly hydrated 






Figure 2.9: Modeling and computer simulation of mMION relaxivity.  In panel 
(a), a core-shell model of an mMION is shown, in which the iron oxide core 
(green) is surrounded by a portion of the coating which excludes water (dark 
blue), and a second layer (light blue) in which there is slow diffusion. Computer 
simulation shows that: (b) R2 decreases as the water exclusion radius (core + 
first layer) increases, where the core size was held constant; and (c) as the 
thickness of the outer layer is increased, R2 increases due to the increased 




 To simulate the effect of coating on water relaxivity, two approaches were 
employed.  In the first approach, only water exclusion from the Core and the inner, 
exclusion layer in Figure 2.9a is considered; protons in the outer layer are assumed to 
behave like bulk water protons.  Therefore, in the model, the water exclusion radius 
(Core + inner layer) determines the minimum distance of approach (measured from the 
center of the iron oxide core) for water protons.  Numerical simulation results for this 
model show a sharp decrease in effective R2 as the thickness of this impermeable coating 
layer is increased (Figure 2.9b).  As is evident in the plot of relative R2 relaxivity vs. the 
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radius from which water is excluded (Figure 2.9b), there is a strong dependence on size 
for particles with thinner coatings, which rapidly tapers off as the coating thickness 
increases above about 10 nm.  The actual mMIONs have approximate coating thicknesses 
ranging from 5 nm (for PEG550, PEG750, and PEG1000) to 15 nm (for PEG2000 and 
PEG5000).  Although the trend agrees qualitatively with the measured relaxivities, it does 
not explain the observed jump that occurs in relaxivity values between PEG750 and 
PEG1000.  This discrepancy suggests a possible opposing effect which is explored in the 
second model below. 
 
 The second modeling approach assumes that there is a layer of coating (outer 
layer Figure 2.9a) that slows down water diffusion without excluding protons.  In this 
model, protons in this layer would spend a longer period of time in close proximity to the 
magnetic field produced by the iron oxide core because the diffusion coefficient of water 
is assumed to be slower than in bulk water.  Evidence exists for such an assumption from 
the structural study of DSPE-PEG micelles by Arleth et al. [60], in which the tightly 
packed hydrophilic shell of their micellar model contains a number of constrained water 
molecules.  Measurements of water diffusion coefficients in solutions of PEG of varying 
molecular weights also indicate that water moves more slowly in such an environment.  
Data collected by Vergara et al. [61] of a range of PEG molecular weights show that as 
the weight fraction of a given PEG solution increases, the mutual diffusion coefficient 
tends to converge to approximately 2.5 × 10-10 m2/s.  Based on this data, a value of 2.5 × 
10-10 m2/s for the diffusion coefficient of water in outer, “slow” layer was chosen. This 
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value is an order of magnitude slower than in bulk water.  The effect of an increasingly 
thick outer layer on R2 relaxivity was thus simulated.  
 
 Results from this simulation (Figure 2.9c) show that as the thickness of the outer 
layer is increased, R2, in fact, increases.  This is not surprising since protons that spend 
more time in the vicinity of the iron oxide core will relax more quickly than those in bulk 
water.  This model thus suggests coating regions of slow diffusion have the opposite 
effect of coating regions that completely exclude water. In isolation, neither individual 
model can explain the trend observed in the experimental data; however, a combined 
water exclusion and slow diffusion model may account for the experimentally observed 
relationship between relaxivity and coating thickness.  To develop a rigorous model to 
accurately simulate the changes in R2 with coating thickness, future simulation work will 
be needed to determine if a combination of these two models, using accurate 
measurements of each layer’s thickness and the water diffusion coefficient in the outer 
layer, can explain the experimentally observed relationship between coating thickness 




 The experimental and simulation studies show that coating properties can have a 
significant impact on contrast agent relaxivity.  While the surface coating’s thickness can 
influence its effectiveness as a contrast agent, it is also important to study the effects of 
surface chemistry on signal enhancement and clearance in contrast agents used in vivo.  
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One specific example of such a study reveals that PEG chain length has a direct impact 
on the blood half-life of a gadolinium-based contrast agent [62].  This study shows that in 
vivo contrast enhancement induced by gadolinium complexes varies with the length of 
the PEG chain to which they are attached.  In the blood pool, for instance, shorter PEG 
polymers (550 and 1000) showed less signal enhancement than PEG2000.  Thus there is 
a complex interplay between coating thickness, coating chemistry, and overall MR 
contrast generated, and all these factors should be carefully considered for the 
optimization of MION-based contrast agents. 
 
 From this study, it can be concluded that the coating thickness of magnetic 
nanoparticle probes can significantly affect their relaxivity. As coating thickness 
increases, there is a dramatic decrease in r2 of the mMIONs, accompanied by less 
dramatic influence on the r1. The results of this study thus have considerable impact on 
the design of magnetic nanoparticle-based contrast agents and their applications in 
medical diagnostics. The numerical simulations provide further insight into the effect of 
coating on magnetic relaxivity of MIONs, suggesting that there are competing factors 
(physical exclusion of protons from the magnetic field source versus longer residence 
time for protons within a certain sphere of coating due to slower diffusion) that determine 









Future Directions: Application to Switchable Nanosensors 
 
Effect of particle clustering on relaxivity 
 Although the magnetization of ferromagnetic colloids was first described in 1938 
[63], it was not until the work of Weissleder, Josephson and others in the early 1990’s 
that the application of iron oxide particles to MRI became widespread [28, 64]. 
Superparamagnetic iron oxide (SPIO) and ultra-small superparamagnetic iron oxide 
(USPIO) particles are valuable because of their ability to be detected by T2 and T2*-
weighted imaging at micromolar concentrations.  
 
 Cellular imaging using iron oxide particles was first applied to hepatic imaging 
[65, 66] where particles are taken up by Kupffer cells. In the normal tissue of the liver, 
these specialized macrophages take up the particles, resulting in hypointensity on MR 
images. The presence of altered tissue types, such as primary liver cancer or secondary 
metastasis, is detected as areas of normal intensity as these tissues do not take up the 
particles. Feridex®, a commercial product of SPIO particles received FDA approval in 
1996 for this purpose. Because macrophages naturally take up SPIOs, imaging of 
structures containing phagocytic cells such as lymph nodes [67, 68] and bone marrow 
[69] were natural extensions of this approach. Although this approach to cellular imaging 
does reveal information about the location of macrophages and can be used to 
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differentiate normal and pathologic tissue, it does not reveal specific molecular 
information. 
  
 In order to achieve greater specificity to targeted cell types, SPIOs and USPIOs 
have been modified with specific ligands. The goal is to modify the surface layer of the 
particle so it binds a specific location on cellular membrane and induces internalization. 
Internalization of the particles, while not specifically necessary for inducing T2 
relaxation, prevents particle interference with cellular interactions as well as particle 
detachment. Modifications to particle surfaces can have a range of specificities. 
Magnetoliposomes [70] non-specifically enhance uptake of particles into non-phagocytic 
cells. The HIV Tat peptide provides a membrane translocation signal that increases 
uptake of particles [23, 46]. Ligands, such as that of transferrin (Tf), have been used to 
target cells expressing the transferrin receptor (Tfr) [9, 71, 72], and dendritic cells have 
been targeted using the CD-11 monoclonal antibody [73]. 
 
 These studies, which involve imaging of cells and cellular processes, are often 
termed cellular imaging. Molecular imaging, however, refers to the study of specific 
molecular events. In some cases such as imaging of macrophages, which non-specifically 
take up particles, there is a distinction. Here the imaging is best described as cellular 
since little molecular information is revealed by non-specific, phagocytic uptake. Imaging 
cells via receptor-mediated uptake is both cellular and molecular imaging since the 
uptake reveals specific molecular information about the cell. Although these contrast 
agents are targeted, they do not specifically change their relaxation characteristics upon 
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cellular uptake. As a result, unbound, background particles cannot be easily differentiated 
from probes that have successfully bound. This also makes quantification difficult. There 
remains a desire for molecular imaging contrast agents to “switch” between states when 
triggered by a specific molecular event. Such a system would result in a change in 
contrast, or relaxation effects, upon specific molecular interactions. In this way, images 
can directly reveal molecular information that can be observed against a background of 
unbound particles.  
 
 Josephson and Weissleder [12] described a system in which DNA binding causes 
a nanoparticle assembly. The concept is based on the outer-sphere theory prediction that 
the relaxation rate (1/T2) is proportional to r2 (r, the radius of the spherical particle). 
They reasoned that when individual superparamagnetic nanoparticles assemble into 
clusters, they effectively act as larger particles leading to an increase in relaxation rate. 
They started with material consisting of monodisperse, fluid-phase nanoparticles 
containing an icosahedral core of superparamagnetic, crystalline Fe2O3/Fe3O4 (3 nm), 
caged by epichlorohydrin cross-linked dextran and functionalized with amine groups 
(CLIO-NH2). Particles were coupled to thiolated oligonucleotides via a N-succinimidyl 
3-(2-pyridyldithio)propionate (SPDP) linker. R2 relaxation was enhanced by 
oligonucleotide hybridization. This change in R2 could be used as a way of “sensing” 
hybridization. 
 
 One potential limit of the work described in the previous approaches to switchable 
contrast systems is the inability to precisely correlate the “switch” or change in R2 with a 
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defined clustering event. The respective oligonucleotides (ODNs), P1 and P2, each had 
an average of three oligonucleotides per MION particle. Figure 2.10a depicts the 
commonly proposed scenario of a single DNA oligonucleotide linking a pair of 
nanoparticles. The “switching” in this case consists of the change in signal caused by 
single ODNs binding DNA and resulting in pairs. However, because there is an average 
of three ODNs per particle, it is possible and likely that larger clusters will form as 
depicted in Figure 2.10b. In this case, the “switching” is a change in signal that occurs 
when single particles cluster into various, unpredictable configurations. This sort of 






Figure 2.10: Clustering of magnetic nanoparticles. The scenario depicted in 
(a) represents a single DNA oligonucleotide linking two magnetic nanoparticles. 
This, however, represents only one of the possibilities of clustering. Since each 
particle has an average of three oligonucleotides attached to its surface, larger 
clusters are likely to form as depicted in (b). The size and frequency of these 






 Since the number and extent of clustering is unpredictable, it will be difficult to 
reliably assign a particular change in signal to a specific clustering event. This limits the 
ability to utilize this approach for quantitative molecular imaging applications. 
Additionally, it cannot be expected that all particles will successfully participate in 
hybridization in an actual imaging experiment. This is especially true of in vivo 
experiments. Inevitably, a more realistic picture of binding will be one in which 
hybridization occurs only in some percentage of particles which could have potentially 
clustered. The change in signal due to switching must be detected against a background 
of unbound particles. Not only does this make detection more difficult, but again it limits 
the possibility of using this system in quantitative molecular imaging experiments. 
  
 
 In order to develop an alternative nanosensor configuration, the concept of the 
“molecular beacon” was employed. In optics, much work has been done to create 
controllable contrast agents using fluorophores and quenchers in configurations known as 
molecular beacons. In 1996, Tyagi and Kramer described novel hairpin-shaped nucleic 
acid detection probes, called "molecular beacons", which undergo a conformational 
transition when they bind to their target that enables them to fluoresce brightly [74]. The 
loop portion of a molecular beacon is a probe sequence that is complementary to a 
predetermined target sequence and the stem is formed by the annealing of complementary 
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arm sequences that are present on either side of the probe sequence. A fluorophore is 
covalently attached to the end of one arm and a non-fluorescent quencher is covalently 
attached to the end of the other arm. In the absence of target, the stem keeps the 
fluorophore and the quencher in close proximity to each other, preventing fluorescence. 
However, when molecular beacons bind to their target, they undergo a conformational 






Figure 2.11: Interaction of a molecular beacon with its target. Binding to the 
target increases the distance between the quencher (black sphere) and the 
fluorophore, allowing it to fluoresce only in situations where a binding event has 
occurred. (Adapted by permission from Macmillan Publishers Ltd: Nature Biotech 




 Although quenchers for magnetic nanoparticles do not exist, this concept can still 
be utilized in the development of switchable nanosensors for MRI. The important feature 
of Figure 2.11 is that there is a change in the signal due to the hybridization event. It can 
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be envisioned that in a molecular beacon approach for MRI, a change in relaxation due to 
hybridization can occur if two or more magnetic particles are either brought together or 
taken apart by the binding event. Although such changes in relaxation are not precisely 
the same on/off event seen in optics, any change in signal is a contrast that may be 
utilized for molecular imaging applications. 
 
  
 An initial test of the molecular beacon approach was developed in collaboration 
with Dr. Gang Bao at Georgia Tech. The goal was to create a novel MION-based probe 
for the detection of oligonucleotide hybridization. A PEG-phospholipid micelle-based 
coating was used. In this design, DNA oligonucleotides of varying length were 
conjugated to the functionalized MIONs at both 5’ and 3’ ends using chemical 
crosslinkers to create a stem-loop hairpin (Figure 2.12a). Hybridization to complementary 
oligonucleotides induced a conformational change from a closed structure (MIONs 
predicted to be in close proximity) to the open, double-stranded structure, resulting in a 
decrease in relaxivity (r2 = (1/T2)/[Fe]; mM-1•s-1) as measured by a 0.47 T Bruker 
Minispec Analyzer MQ20. Decreases in relaxivity upon increase of distance between 
bound particles were observed experimentally (Figure 2.12b). By varying the length of 
the hairpin DNA in future work, the contribution of changes in distance between the 






Figure 2.12: Experimental system demonstrating clustering effect on 
relaxivity. a) Upon hybridization to a complementary target, a 40-nucleotide 
hairpin (sequence = 5’-thiol AAA AAG CAG CCA GCC AGT CTA GTC TAG TTT 
GCT GCA AAA A thiol-3’) changes from the closed conformation (left) to an open 
conformation (right), increasing the distance between the two magnetic particles 
and decreasing their r2 (mM-1s-1). b) A decrease in r2 was observed by the 




Simulations applied to switchable systems 
 
 While clustering systems have been experimentally demonstrated to alter 
relaxivity, their effects have not been systematically examined theoretically. Here, 
computer simulations have been used to study the clustering effect. Monte Carlo 
simulations were performed as described above. In this case, however, particles were 
allowed to come together in various configurations (Figure 2.13). Issues explored 
included the effect of number of particles involved in clustering and binding distance 
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between particles. Additionally, it can be anticipated that systems will be imperfect, 
resulting in a limited number of particles coming together. Limited clustering must be 
detectable against a background of unclustered particles. Therefore, binding efficiency 




Figure 2.13: Clustering configurations. Two, three, and four particle 
configurations with d, distance between particle centers. Simulation parameters 
include d, binding efficiency, core size, coating size, coating properties, motion of 




 Here, an additional parameter, binding efficiency, (b.e.) was defined to represent 
the percentage of successful clustering. For instance, for 1000 particles, in the case of two 
particle clustering, a b.e. of 1.0 corresponds to 500 pairs. A b.e. of 0.5 corresponds to 250 
pairs and 500 free particles. For the four particle case, a b.e. of 1.0 corresponds to 250 
clusters whereas a b.e. of 0.5 corresponds to 125 clusters and 500 free particles. 
Simulations were performed varying binding efficiency, binding distance and number of 
particles involved in clustering. 
 
 57
 In all cases, values for R2 and R2* are the same. This is expected for the motion 
averaging regime for superparamagnetic particles of small radius. Figure 2.14a shows an 
approximately linear effect of binding efficiency on R2. A binding efficiency as low as 
25% can be distinguished from the case of no binding. Figure 2.14b shows the increase in 
R2 with particle number involved in clustering. Figure 2.14c shows the effect of binding 






Figure 2.14: Simulated clustering effects. a) Effect of Binding Efficiency on 
R2. b) Number of particles involved in clustering vs. R2. Data plotted for constant 
binding efficiency of 1.00. c) Effect of Particle Binding Distance on R2. Data 





 There results indicate that significant changes in R2 can be achieved in cases of 
limited clustering. Low binding efficiencies can be expected in in vivo applications of 
molecular imaging, thus requiring the identification of positive binding in a background 
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of unbound particles. The results also indicate that clusters involving small numbers of 
particles can be distinguished, as may be desired in “molecular beacon” type applications. 
The flexibility in binding distances allow for the assembly of complex structures of 
particles with various sensing and targeting molecules. These results are useful for 
designing switchable magnetic nanosensors and applications where a limited number of 




Simulations of effect of coating size on clustering 
 
 Particle size and hydrodynamic radius appear to have significant effects as 
discussed above and may become important considerations in probe design for clustering 
applications. To further address this issue, changes in particle and coating sizes were 







Figure 2.15: Simulated effect of particle size and coating on the clustering 
effect. Table (a) showing increased clustering effect (∆R2) with larger core size 
and graphs (b and c) showing that for constant core size, increased particle 
diameter (by increased coating size) results in a decrease in maximum effect due 
to clustering. In (a), the total particle diameter is 40 nm, but the magnetic core 
size is varied. In (b) and (c), each line represents a fixed magnetic core size, but 
the overall particle diameter is varied by increasing the coating thickness 




 Figure 2.15a demonstrates that for a fixed particle diameter of 40 nm (core plus 
coating), larger core sizes and greater number of particles increase the clustering effect. 
In the table, all particles were 40 nm in overall diameter, meaning that particles with 
smaller cores had relatively larger coatings. The clustering was performed by allowing 
these particles to come together as close as possible (40 nm center-to-center distance). 
For particles with smaller cores (larger coatings), the change due to clustering (∆R2) is 
reduced since the magnetic fields of the particle cores cannot overlap as much as in the 
case of larger cores where the larger magnetic crystal and relatively smaller coating 
allows for magnetic fields to overlap, creating a greater clustering effect.  
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 Figures 2.15b and 2.15c demonstrate that while clustering effects are larger when 
core size is increased, these effects diminish rapidly when overall particle size increases 
as is the case when coating size is increased. Clusters involving larger core sizes, with 
minimal coating thickness are optimal for maximizing the effect of clustering. The results 
show that the coating thickness is an important consideration in the design of activatable 







 The development of the computer simulation used for these studies provides a 
useful tool for many other contrast agent studies. Computer simulations allow for the 
controlled study and testing of individual factors in determining overall relaxation 
properties. By incorporating individual properties into simulation and systematically 
reviewing their effect, a picture of the relative contribution of factors to the overall 
observed T2 can be obtained. This is especially useful in planning future design of 
nanoparticle probes, as complicated chemical preparations can be time consuming and 
difficult to synthesize. By first testing hypothetical probes in simulation, potential 




 The main value of such a simulation is that it allows for testing hypotheses on the 
effects of nanoparticle parameters relatively quickly and independently, without 
synthesizing each particle. Additionally, in actual synthesis, it may be difficult to change 
a single parameter without affecting others, thereby making the relative contribution of 
each factor in overall R2 change difficult to assess experimentally.  
 
 While simulation can provide a tool for understanding T2 relaxation, the validity 
of results cannot be verified without laboratory testing of actual nanoparticle designs. 
Additionally, the interplay of environmental factors in experiment can prove to be too 
complicated to be fully incorporated in simulations involving nanometer sized objects.  
 
 Nevertheless, future simulations can be used to refine these models to gain a more 
comprehensive mechanistic understanding of the processes determining the proton 
relaxation characteristics of MIONs.  By carefully studying all the factors that influence 
the relaxation properties of a contrast agent, it will be possible to optimize the design of 
magnetic nanoparticle probes for specific applications, including the imaging of the blood 




OFF-RESONANCE SATURATION AS A MEANS FOR 







 Typically, superparamagnetic iron oxide (SPIO) contrast agents are used for their 
effect on T2 or T2* [20]. They have been applied to liver imaging and are increasingly 
being investigated as tools for in vivo tracking of stem cells and tumor progression [22, 
23]. Additionally, biocompatible particles have been linked to specific ligands for 
targeted molecular imaging applications [7-11]. While most of these studies have met 
with some success, a significant limitation has been the inability to positively identify 
iron oxide contrast agents. This is largely because in T2 or T2* weighted images, 
magnetic nanoparticles lead to signal reduction and sometimes signal voids. In such 
images, it is difficult to estimate nanoparticle concentration, and quantification would 
require T2 or field mapping. When particles are present in high concentrations, the border 
of signal void can extend out, causing overestimation of particle extent.  
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 In addition, signal voids can be caused by other factors including field 
inhomogeneities and susceptibility-induced artifacts from macroscopic field 
inhomogeneities such as those at tissue interfaces. In molecular imaging applications 
using iron oxide nanoparticles, these issues make identification of labeled cells 
inconclusive. At high magnetic fields, which are becoming widely used in clinical 
practice, the sensitivity to susceptibility-induced artifacts from such macroscopic field 
inhomogeneities is increased. 
 
 Given that the particles cause local field inhomogeneities, it is also possible, by 
the application of off-resonance irradiation, to exploit the effect of field inhomogeneity as 
an alternative contrast mechanism for these agents. There has been recent work seeking 
to generate positive contrast for superparamagnetic particles [75-77]. In the white-marker 
method [75, 76], positive contrast labeling is used to track catheter-based paramagnetic 
markers, such as those used during endovascular interventions. This technique relies on 
the dipolar field surrounding paramagnetic markers by introducing a dephasing gradient 
on the slice-select axis to spoil signal across the sample. In regions where the local 
gradients surrounding the paramagnetic marker are of the right amplitude and orientation, 
however, the signal becomes refocused. The resulting image shows a signal void 
everywhere except in the voxels containing paramagnetic marker. In off-resonance 
excitation [77], a spectrally selective pulse is used to excite only those protons influenced 
by the magnetic field of particle-loaded cells.  
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 These methods generate images that contain signal only in areas corresponding to 
locations of magnetic particles. Furthermore, the white-marker method is only sensitive 
to macroscopic field inhomogeneity caused by paramagnetic material and both methods 
are only sensitive to a volume surrounding the paramagnetic material having the correct 
field variation or field. Due to the latter point, the amount of signal that can be generated 
is limited.  
 
 Here, a diffusion-mediated off-resonance saturation method for generating 
contrast using ultrasmall SPIO (USPIO) nanoparticles is demonstrated and examined. In 
this method, bulk water protons are imaged with and without the presence of an off-
resonance saturation pulse. Unlike chemical exchange dependent saturation transfer 
(CEST) contrast agents [19], which function by reducing the water proton signal through 
a chemical exchange site, this method relies on diffusion of water molecules around the 
iron oxide nanoparticle. Compared with the white-marker method and the off-resonance 
excitation method, the present method is sensitive to microscopic effects of USPIO and to 
all water protons that are affected by the USPIO due to diffusion.  
 
 The effect of the off-resonance saturation (ORS) on the image intensity in the 
presence of magnetic nanoparticles is examined experimentally. It is demonstrated to be 
distinct from the exchange-mediated magnetization transfer (MT) effect [17] and can be 
seen even in the presence of MT. Additionally, the dependences of this ORS effect on 






 In the presence of an external magnetic field, superparamagnetic particles alter the 










Bz     (3.1) 
 
 The resulting magnetic isosurfaces define shells surrounding the particle (Figure 
3.1a). Figure 3.1b shows the relative compartment size of a 100 Hz volume for different 
sized particles. Application of appropriate off-resonance irradiation saturates protons in 
some shell surrounding the particle, and diffusion leads to an apparent partial saturation 
of a volume near the shell determined by offset frequency, bandwidth, and diffusion in 
the time of the off-resonance irradiation, causing a signal reduction. From the spatial 
distribution of a dipole field, it is anticipated that larger off-resonance (∆ω) occurs in 
small shells near the particle, leading to smaller effect, and smaller ∆ω occurs in larger 





Figure 3.1: Particle dipole field lines create shells surrounding the particle. 
a) Plot of field isolines surrounding the particle as approximated by a dipole. + 
and – indicate positive and negative values for the field. The magnitudes of 
plotted lines (from inner to outer lines) are: 235, 117, 23, 2.3, 0.2 µT. b) Relative 
volumes in 100 Hz compartments for particles of varying diameter. The center 





 In addition to saturation volume defined by the shell influenced by the off-
resonance irradiation, the ORS effect depends on diffusion rate as this relates to the 
amount of time a proton spends in the shell, δt. Although these shells are small, repeated 
replacement of protons by diffusion and consequent saturation of these new spins within 
each shell should result in amplification of the ORS effect. The spatial extent of protons 
affected by the ORS pulse is determined by the diffusion during the duration of the pulse, 
if we assume that the thickness of the shell is much less than the diffusion distance.  On 
the other hand, flip angle of water protons in the targeted shells depends on δt by the 
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relation, α = γB1δt. These factors result in a nonlinear dependence on δt. This has been 






 Iron oxide particles with a core size of 6.6 nm and a PEG-phospholipid coating 
were prepared as previously described [41]. These micelle-coated MIONs (mMIONs) 
had an overall hydrodynamic diameter of 12-14 nm as determined by dynamic light 
scattering (DLS) and electron micrography. Dilutions were made using 1× Dulbecco’s 
phosphate buffered saline (PBS) without Ca2+ or Mg2+ (ICN, Ohio). Dilutions of Feridex 
(Advanced Magnetics, Inc., Cambridge, MA) were made in citrate buffer. For pH 
experiments, imaging was performed on five sets of particle solutions at concentrations 
of 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, and 1.0 mM Fe, adjusted to pH values of 6.0, 7.0, 8.0, 
9.5, and 10.9, respectively, using NaOH and HCl.  
 
 Agarose gel phantoms were made by first preparing a 2% agarose plate. 
Cylindrical plugs were removed and molten 2% agarose with various concentrations of 
nanoparticles was poured into the vacant areas on the plate. The resulting 2% agarose 
plate contained no physical boundary between areas of particles and areas devoid of 
particles. For diffusion experiments, Feridex particles were prepared in three 
concentrations (0.2, 0.5 and 1 mM Fe) in various solutions of PEG-400. Vergara et al. 
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[61] have previously measured mutual diffusion coefficients in these solutions showing 
that increasing PEG-400 weight fraction corresponds to decreasing diffusion rate. 
Preparations were made using weight fractions, Wi = 0.01, 0.15, 0.25, and 0.45, 
corresponding to diffusion coefficients, Di = 0.44, 0.41, 0.37, and 0.29 × 10-9 m2/s 
respectively. The diffusion constant of bulk water, Wi = 0, is taken to be 2.5 × 10-9 m2/s. 
 
 Imaging was performed on a 3T Siemens TRIO scanner (Siemens Medical 
Solutions, Malvern, PA) using a FLASH sequence (for solution images: TR/TE 35/4.8 
ms, flip angle 20°, matrix size 256 × 256, FOV 128 mm, slice thickness 5 mm; for 
agarose images: TR/TE 40/4.8 ms, flip angle 15°, matrix size 256 × 256, FOV 200 mm, 
slice thickness 4 mm; and for diffusion measurements: TR/TE 36/4.8 ms, flip angle 15°, 
matrix size 128 × 128, FOV 150 mm, slice thickness 3 mm). Off-resonance irradiation 
was accomplished by applying a 6 ms Gaussian pulse in each TR prior to imaging pulses. 
Offset frequency (∆ω) and power of off-resonance pulse were varied. All images were 










Results and Discussion 
 
 In order to quantify the magnitude of the ORS effect, the ratio, 1-(Msat/M0), where 
Msat represents the image taken with off-resonance irradiation and M0 represents the 
image without it, was calculated. This ratio is analogous to the magnetization transfer 
ratio (MTR) used in magnetization transfer contrast (MTC) imaging. The ORS ratio 
refers to the quantification of the off-resonance effect due to diffusion around SPIO 
particles. Increased ORS effect is reflected in higher ratios. It is conceivable that a 
contrast agent could be developed to employ both MT and ORS.  
 
 
Concentration and ORS 
 In Figure 3.2, a FLASH image obtained without off-resonance irradiation (left) 
and a ratio image (right) are shown. In the ratio image, it can be seen that the control 
buffers show little signal and the ability to identify particle samples increases with iron 
concentration. Concentrations as low as 0.02 mM Fe can be visually distinguished from 





Figure 3.2: Standard and off-resonance MRI of particle solutions. a) FLASH 
image of Feridex (top two rows) and mMION (bottom two rows) samples in 2.0-
ml tubes, b) ORS ratio image showing increasing ratio with concentration for both 
Feridex and mMION samples. The sample order for each set of two rows (in mM 
Fe) is: 0 (buffer only, citrate for Feridex and PBS for mMIONs), 0.01, 0.02, 0.05, 




 The off-resonance irradiation results in a decrease in signal and corresponding 
increase in ORS ratio that is dependent on concentration and power of off-resonance 
pulse (Figure 3.3). In the figure, each line corresponds to a plot for a single concentration 
of particles expressed as mM Fe. There is a maximum power above which further 




Figure 3.3: ORS ratio vs. power of off-resonance pulse. Plots are for several 
concentrations of iron indicated by the legend. The plots tend to flatten out at a 





 As expected, increasing concentration results in an increase in ORS effect. 
Although this increase is linear for low concentrations, it becomes nonlinear at higher 
concentrations where the inter-particle distance shortens to a point that fields arising from 
adjacent particles overlap significantly, and ORS effects from adjacent particles do not 
simply add. Taking the expected magnetization as 65 emu/g Fe at 3T [28], it is estimated 
that at the offset frequencies used, the targeted shells are approximately 100 nm from the 
particle center. At 0.05 mM Fe, the interparticle distance is approximately 400 nm, 
making shells from adjacent particles on the order of 200 nm apart. At this distance, 
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taking the diffusion contribution into account, it is conceivable that contributions from 
neighboring particles are not independent and may be less than simple summation.  Given 
this argument, it is not surprising that increases in concentration above 0.05 mM resulted 






Figure 3.4: Plot of ORS Ratio vs. Iron concentration for varying offset 




 As ORS ratio increases with concentration linearly at concentrations below 
saturation, the ORS approach can be used as a simple method for quantification of 
nanoparticles in an image. Correlating signal with concentration can reveal not only the 
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presence of a disease, but also its severity. For instance, Zimmer et. al. [78] showed a 
correlation between magnetic particle uptake and the number of thymidine kinase 
positive cells in a rat gliosarcoma model. Also Roberts et. al. [79] reported that 
concentration of contrast agent can be used to determine microvascular permeability, 
which correlates strongly with tumor grade. For intracellular applications, such as the 
detection of macrophage activity, the relationship of ORS and concentration may become 





 Figure 3.5 shows the dependence of the signal intensity on the frequency of the 
off-resonance pulse. The line for pure water represents signal loss due to direct 
saturation, and is therefore viewed as control for assessment. The difference between the 
pure water curve and that for samples containing particles reflects the ORS effect. The 
data suggests a useful offset range of 500 Hz < │∆ω│ < 1500 Hz, below which direct 










Magnetization Transfer and ORS 
 At the off-resonance frequencies used, it is important to examine the ORS effect 
along with magnetization transfer (MT), as both are likely present in in vivo applications. 
The ORS effect is distinct from the MT effect in that it relies on the diffusion of water 
molecules among different compartments, the borders of which are defined by magnetic 
field isosurfaces and not necessarily by physical separation. In MT, a chemical or 
otherwise physical exchange of protons occurs [17]. In order to ascertain that the ORS 
effect is not due to MT, it was studied in solutions of varying pH. Gossuin et. al. [58, 80] 
have previously used this approach to distinguish between outer and inner sphere effects. 
OH groups located at the surface of hydrous particles exhibit amphoteric behavior (see 






Figure 3.6: OH groups located at the surface of particles have differing 
numbers of exchangeable protons depending on pH. At low pH, the surface 




 The surface is more protonated at low pH than at high pH. Relaxation is more 
pronounced at low pH due to the larger number of exchangeable protons. The proton 
exchange from these groups can be controlled by varying pH. Since changes in pH affect 
the rate of exchange, an MT like process will be affected by pH whereas the ORS effect, 
primarily dependent on diffusion, should remain constant over variations in pH for which 
the nanoparticles remain stable. Figure 3.7 plots the ORS ratio for Feridex obtained at 
different pH.  The independence of the ORS ratio from pH suggests that it is a process 








Figure 3.7: ORS Ratio vs. pH plotted for the different offset frequencies. 
The independence of the ORS effect from pH suggests diffusion rather than 




 In in vivo applications where MT is present, there is concern that the ORS effect 
may not be large enough to be observed. Magnetization transfer appears in tissues 
throughout the body, and agar is often used in phantoms to represent these tissues [81]. 
Therefore, a phantom was created made from 2% agar with embedded particles at various 
concentrations. In Figure 3.8, these particles can be seen in the left image as darkened 
areas within the phantom. On the ORS ratio image on the right, embedded particles can 
be identified within the agar (which also shows MT effect) indicating that this effect can 
be observed even in the presence of magnetization transfer. Since MT and ORS operate 
via different mechanisms, their effects are additive. For in vivo applications where it may 
be desired to separate these effects, it is possible to quantify MT prior to application of 







Figure 3.8: Agar phantom (2%) with embedded particles. Concentrations in 
mM Fe: a) 0.5 b) 0.25 c) 0.125 d) 0.063 e) 0.031. The left image is taken without 
off-resonance pulses, and the image on right is the ORS ratio. TR 40 ms, TE 4.8 







 Given that the ORS approach is based on an off-resonance frequency, it will 
depend on the B0 inhomogeneity. An additional concern is fat resonance, which at 3T is 
nearly 500 Hz. This should be considered, and it may be necessary to restrict in vivo 
applications to the positive portion of the dipole in order to avoid confusion with fat 
suppression. 
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Diffusion and ORS 
 
 Figure 3.9 shows an image of samples obtained without off-resonance irradiation 
(left) and an image corresponding to the ORS ratio (right), where Msat was obtained with 
1000 Hz offset irradiation. Each row of samples contains a single concentration of iron. 
Weight fraction of PEG-400 increases across the row, corresponding to decreasing 
diffusion rate from left to right in the images. Because of the increasing weight fraction 
of PEG-400, and corresponding decrease in water content, signal intensity decreases 
across the row in the standard image on the left side of the figure. In the ORS image, it 
can be seen that pure water shows little signal, and samples along each row show 





Figure 3.9: MRI showing diffusion dependence of ORS effect. FLASH image 
of samples obtained without off-resonance irradiation (left) and an image 
corresponding to the ORS ratio (right), where Msat was obtained with 1000 Hz 
offset irradiation. Iron concentration is constant across each row: 1) no particles, 
2) 0.2 mM Fe, 3) 0.5 mM Fe, 4) 1.0 mM Fe. Weight fraction of PEG-400 
increases across the row: Wi=0, 0.01, 0.15, 0.25, and 0.45, corresponding to 
diffusion coefficients, Di=2.5, 0.44, 0.41, 0.37, and 0.29 ×10-9 m2/s respectively. 
TR 36 ms, TE 4.8 ms, flip angle 15º. 
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 For a constant offset frequency of 600 Hz, the ORS ratio versus PEG-400 weight 
fraction is shown in Figure 3.10a and that versus diffusion constant determined according 
to reference [61] is illustrated in Figure 3.10b. Data show that the dependence on water 
diffusion becomes most significant at rates of 0.5 × 10-9 m2/s and slower, although this 
dependence is expected to vary with the ORS pulse length and the off-set frequency. 
Lutsep et. al. [82] reported that the diffusion coefficient in ischemic lesions increased 
with time after symptom onset, from 0.29 – 0.33 × 10-9 m2/s for ischemic lesions at less 
than 8 hours, to 0.61 ± 0.14 × 10-9 m2/s at 8-24 hours and 0.51 ± 0.18 × 10-9 m2/s at 1-8 
days, and eventually to a value of 2.63 ± 0.37 × 10-9 m2/s at 5 months after symptom 
onset. Therefore, ORS may be useful in the follow-up of stroke recovery. Additionally, 
Desprechins et. al. [83] showed that brain abscesses result in diffusion coefficients in the 
range of 0.21 − 0.34 × 10-9 m2/s and that this can be used to distinguish them from 
intracerebral necrotic tumors which are frequently impossible to differentiate with 








Figure 3.10: Plots of ORS ratio. a) ORS ratio vs. PEG-400 weight fraction and 
b) ORS ratio vs. diffusion constant for a constant offset frequency of 600 Hz. For 




 As mentioned above, the ORS ratio should be related to δt, the amount of time 
needed for a proton to traverse a particular shell, in a non-linear manner. Here, δt should 
depend on shell size and diffusion rate. In order to test this, this ORS effect was studied 
at different offset frequencies (∆ω). Decreasing ∆ω corresponds to shells further from the 
particles and larger in size. The dependence on diffusion should vary with offset 
frequency. As can be seen in Figure 3.11, as ∆ω decreases and hence the shell size 
increases, the ORS effect not only increases but also exhibits less dependence on 





 Taking the above together, it is likely that the dependence on the diffusion arises 
from opposing consequences of the diffusion rate. Slower diffusion rates result in longer 
residence times within targeted shells, allowing for greater energy absorption. At the 
same time, slower diffusion decreases the rate at which fresh spins are entering shells, 
and hence the spatial extent of the effect. These data suggest that the dependence on 





Figure 3.11: ORS vs. Diffusion Rate, obtained at various off-resonance 
frequencies. ∆ω noted in the legend. These plots indicate the dependence on 





A Model for ORS 
 In order to further understand the ORS effect, a simple model can be assembled 
based on the dependencies examined above. The effect increases with increasing iron 
concentration. It increases with shell size, but it is also highly dependent on diffusion. As 
discussed earlier, the dependence on diffusion can be related to δt, where δt represents the 
time a proton spends in a particular shell. While this should not be considered a complete 




δγ )cos(1 1−=             (3.2) 
 
where k is a proportionality constant and Vshell is the volume fraction of targeted water 
shells which depends on the particle’s magnetization characteristics, its concentration, 
and the frequency of offset-resonance irradiation. T represents duration of the off-
resonance irradiation, on the order of milliseconds, while δt is on the order of tens of 
nanoseconds to microseconds, depending on the shell size. TVshell/δt therefore accounts 
for the diffusion-mediated saturation volume, which has a greater extent than the volume 
defined by the off-resonance frequency alone. A simple estimate of δt can be made using 
the volume of the shell and the diffusion relation tDzrms δ2=∆  where ∆zrms is taken as 
the average thickness of a given shell. Equation 3.2 leads to curves in Figure 3.12, which 
show increased ORS for lower diffusion constants as well as lower offset frequencies, in 






Figure 3.12: Plots of model showing nonlinear dependence of ORS on 
diffusion rate. Each plot corresponds to a single offset frequency. Increased 
ORS is observed for lower diffusion constants as well as lower offset 




 The dependence on diffusion suggests the possible use of ORS as a method to 
estimate diffusion rates using SPIO. In clinical applications, this approach may be useful 
in organs and diseases where diffusion may be altered by pathology. As discussed earlier, 
these include ischemic lesion follow-up and differentiation between tumors and 
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abscesses. Further development of the above model, along with numerical simulation can 
be carried out to gain additional insight into this effect.  
 
 In order to achieve a higher offset frequency, the magnetic moment of the particle 
may be increased. There is a tradeoff, however, as larger particles are more likely to 
interfere with cellular functions rendering them less desirable for many molecular 
imaging applications, where targets may be clustered on cell-surfaces or within the cell 
itself. 
 
 In the present work, a Gaussian pulse was applied every TR and the steady state 
magnetization thus depends on the pulse width and energy of applied RF and magnetic 
characteristics of particles. Just as in the case of chemical exchange agents [84], this 
effect is dependent on power of irradiation. It is expected that optimal irradiation may 
depend on the particle characteristics because of both differing magnetic properties and 
differing coating characteristics, which influence diffusion around the particle. It is also 
possible that contrast agents employing both chemical exchange and ORS may be created 











 This work describes and demonstrates an off-resonance saturation approach to 
probe the effect of superparamagnetic particles. This method allows for the generation of 
an image in which there is a positive correlation between image intensity and 
superparamagnetic nanoparticle concentration. The ORS effect is not limited to the 
volume of the spins at a particular frequency offset, but is amplified by diffusion in the 
duration of the saturation pulse. Given that the full width at half maximum of the pulse (3 
ms) is several folds longer than that (0.7 ms) of the off-resonance excitation pulse [77], 
the ORS effect is expected to be proportionally larger. In addition, the effect is highly 
dependent on diffusion suggesting that the approach may be useful in situations where 




The material in this Chapter is republished from [85] in Magnetic Resonance in Medicine 











The term “magnetotactic bacteria” refers to many different species of bacteria that 
make chains of magnetic crystals called “magnetosomes” inside their cells. These 
bacteria move along the lines of a magnetic field in a process called “magnetotaxis”. It 
was this unique property that led to the initial identification of these bacteria from Cape 
Cod marshes more than thirty years ago [86] and the subsequent discovery of the 
magnetosome. These structures are comprised of a magnetic iron oxide crystal core, 
surrounded by a phospholipid membrane. Each species of magnetotactic bacteria has a 
different, but specific, type and shape of magnetosome. However, due to their difficulty 
to isolate and maintain in culture, only a small portion of magnetotactic bacteria have 
been studied [87]. Although the complex biological process is not fully understood, there 
are numerous practical applications of such precise and uniform magnetic nanoparticles 
in research and industry.  
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These biologically produced, magnetic particles affect the MRI signal in the same 
way as synthetic superparamagnetic iron oxide (SPIO) nanoparticles [20] which have 
already been used for targeted molecular imaging applications [7-11]. One major 
application of these SPIO nanoparticles is the in vivo tracking of stem cells [22, 23] and 
tumor progression [11]. Labelling non-phagocytic cells in culture using modified 
particles, followed by transplantation or transfusion in living organisms, has made it 
possible to monitor cellular distribution in vivo, including cell migration and trafficking. 
A limitation of this approach is the need to label cells in vitro with pre-synthesized 
nanoparticles prior to cell transplant. As a result, particle concentration within cells 
decreases over time as the cells grow, migrate, and divide and particles cannot be readily 
linked directly to in vivo gene expression.  
 
One way to overcome this is to utilize a genetic approach. GFP is perhaps the 
most well-known genetic marker for optical imaging. Magnetic resonance spectroscopy 
(MRS) has been used to detect creatine kinase [88] and chemical shift imaging (CSI) to 
observe beta-galactosidase [89] activity. MRI reporter strategies thus far have focused 
primarily on the detection of beta-galactosidase activity [90, 91] and expression of 
natural iron homeostasis proteins such as the transferrin receptor [92] and ferritin [93]. 
For the transferrin receptor approach, administration of exogenous transferrin coupled to 
magnetic particles is required. Thus far, only ferritin exists as a purely in vivo MRI 
marker, but its relaxivity is approximately 700 times lower than that of 
magnetite/maghemite (iron oxide) particle solutions [94], leading to the desire for a 
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genetic approach to produce iron oxide relaxation agents. This has led to the desire to 
seek out a gene reporter for MRI based on the genetics of the bacterial magnetosome. 
 
The ability to produce magnetic nanoparticles, of the same composition as 
synthetic SPIO preparations, in a novel host cell type would open up the possibility of 
many additional biotechnological applications. For instance, many molecular imaging 
applications envision targeting contrast agents to specific receptors or cell surface ligands 
and disease specific markers. Iron oxide particles are also used in the manufacture of 
magnetic tapes and printing ink, magnetic targeting of pharmaceuticals, and for cell 
separation [95]. Synthetic particles, however, are often non-uniform, non-homogeneous 
in composition, and difficult to disperse evenly in solution. One possible solution could 
be to replace these particles with isolated bacterial magnetosomes. Advantages of this 
approach over synthetic nanoparticle production include uniformity and potential lower 
cost of the bacterial magnetosomes. Additionally, the phospholipid membrane 
surrounding the particles renders them water soluble, a difficult achievement for many 
synthetic nanoparticle processes. In fact, various applications of isolated magnetosome 
particles have already been explored. Magnetosomes have been conjugated to antibodies 
and used to detect and remove E. coli cells from bacterial suspensions [96] as well as in 
the detection and quantification of the immunoglobulin, IgG [97]. 
 
The major limitation of this approach, which would require growing 
magnetotactic bacteria in large quantities, is the sensitivity of magnetotactic bacteria to 
oxygen, making these strains difficult to isolate and maintain in culture [87]. Particles 
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formed in novel cell types, by engineered biological processes, could potentially replace 
these sources of particles without the need for extreme temperature, pH, and pressure 
protocols often required for industrial synthesis of iron oxide nanoparticles, nor the need 
for low-oxygen culture techniques for preparation of native magnetosomes. 
 
It is likely that natural magnetosome production requires multiple genes. Recent 
work has identified a 98 kb genomic island [98], among other regions, in the 
Magnetospirillum sp. strain AMB-1 related to magnetosome regulation, and iron 
response studies have revealed 464 upregulated and 263 downregulated genes [99]. Our 
efforts here focus on magA, a gene known to be involved in the production of 
magnetosomes in M. magneticum [87, 100, 101]. Nakamura and co-workers [100, 101] 
found that magA encodes a protein with high sequence homology to the cation-efflux 
proteins, KefC, a K+-translocating protein in E. coli, and NapA, a putative Na+/H+ 
antiporter from Enterococcus hirae. With magA expressed in E. coli, inverted membrane 
vesicles prepared from these cells were shown to transport Fe(II) in an energy-dependent 
manner, leading to accumulation of Fe(II) in the vesicle. These observations indicate that 
MagA functions as an H+/Fe(II) antiporter in M. magneticum AMB-1 (Figure 4.1). 
Consistent with this, a recent full genomic analysis of M. magneticum AMB-1 found 
deletions in magA among a set of nonmagnetic mutants [102]. Although the complete 






Figure 4.1: MagA is a transmembrane protein. MagA is thought to function as 





Initial Transfection Results 
 
In order to test the magnetosome concept, the gene was initially cloned into a test 
vector consisting of magA expressed under the constitutively expressed cytomegalovirus 
(CMV) promoter for transfection studies. These results show initial testing prior to 
cloning the gene into an inducible vector for long-term study. This test vector contained 
magA under control of the CMV promoter with IRES-GFP so that positively transfected 
cells could be identified by fluorescence. A control vector contained the GFP protein 
under control of the constitutively expressed CMV promoter. 
 
293FT cells were grown under standard culture conditions using Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 
L-Glutamine, Penicillin, and Streptomycin. Calcium phosphate transfection was used to 
deliver the magA vector as well as the control vector. Untransfected cells were also 
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maintained as an additional control. Following transfection, media was replaced and the 
cells were allowed to incubate for an additional 24 hours. Transfection efficiencies of 
greater than 50% were observed by fluorescence microscopy. Cells were then divided 
into separate plates and one-half of each sample was incubated an additional 48 hours in 
media supplemented with 50 µM ferric citrate as a source of iron. The remaining half of 
each cell sample was incubated in standard media. 
 
Cells were then trypsinized and collected. 107 cells were counted from each 
sample and spun for 2 minutes at 1000 rpm in 15 mL falcon tubes. Cells pellets were 
imaged using a Siemens 3T Trio MR scanner. T2 times were calculated using a Carr-
Purcell-Meiboom-Gill (CPMG) sequence. Figure 4.2 shows the relaxivity results. There 
are eight total samples. Samples 1 and 2 show that iron supplied in the media cannot by 
itself alter relaxivity. This is expected since the free iron does not form a great enough 
magnetic moment in comparison with the magnetic domains formed by crystalline iron 
oxides. Samples 3-8 contain cells and all have increased relaxivity when compared to the 
media only samples. Samples 3 and 4 show that cells alone cannot form iron oxide 
crystals, even when supplemented with iron. Sample 5 shows that cells transfected with 
the magA gene do not form iron oxide crystals without the addition of a source of iron. 
Sample 6 shows that both magA gene transfection and iron supplement do result in the 
formation of structures capable of altering relaxivity. Samples 7 and 8 show that 







Figure 4.2: Initial relaxivity testing. Relaxivity for samples measured using 





Figure 4.3 shows two images taken from the CPMG sequence used for T2 
measurement. Figure 4.3b indicates that at an echo time of 125 ms, the sample containing 
cells transfected with magA and supplemented with iron has induced signal decay 
sufficient to differentiate it from all other samples. This indicates the feasibility of using 







Figure 4.3: Images from CPMG sequence. a) Echo time 25 ms. b) Echo time 
125 ms. See Figure 4.2 for sample descriptions numbered 1-8. At 125 ms (b), the 
cells transfected with magA and supplemented with iron (sample 6) can be 





Figure 4.4 shows iron staining of cells transfected with magA. The blue color of 






Figure 4.4: Histology of whole cells using iron stain (Prussian blue) with 
nuclear fast red counter-stain. a) 293FT cells without Fe supplement (20X), b) 
293FT cells with Fe supplement (20X). c) 293FT cells transfected with magA 
without Fe supplement (20X). d) 293FT cells transfected with magA with Fe 
supplement (20X). e) higher magnification (60X) of 293FT cells transfected with 
magA with Fe supplement. The sample with magA and iron supplement showed 
a blue color indicating the presence of iron. Cells were washed twice with PBS 
prior to mounting. 
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In vivo production of magnetic nanoparticles via magA expression 
 
In order to demonstrate the production of magnetic nanoparticles in a mammalian 
system, the magA gene was expressed in a tetracycline/doxycycline inducible lentiviral 
vector. In addition to achieving stable cells capable of expressing magA, the inducible 
system allows specific control of magA gene expression in response to doxycycline. In 
this way effects of magA expression could be systematically studied by varying 
doxycycline administration. A clonal cell line, 2B5, was established from 293FT cells, 
following viral infection and confirmed by the presence of magA. This cell line was used 
in subsequent experiments described below. 
 
To analyze the imaging potential of this cell line, MRI studies were performed in 
cell culture with and without the expression of magA by the addition of doxycycline, as 
well as with and without iron supplement as a source for producing the iron-oxide 
nanoparticles. The inset in Figure 4.5a shows two images taken from a multi-echo, Carr-
Purcell-Meiboom-Gill (CPMG) sequence. Because iron-oxide particles shorten T2, the 
MRI signal in nanoparticle containing cells decays with echo time (TE) faster than that of 
normal cells, resulting in a darkening of the image and readily detectable contrast. The 
transverse relaxation rate (R2, R2≡1/T2), calculated from the imaging data, is also shown 
in Figure 4.5a. These results demonstrate no change in R2 without induction of gene 
expression and a significant increase in R2 upon induction and supplementation of iron. 
This cell line has been passaged continuously over 8 months with stable integration of the 
magA gene (verified by PCR) and exhibited consistent relaxation rates at all passages. 
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Figure 4.5: MRI of magA cell line. a) Transverse relaxation rates (R2) of cell 
cultures. Increased R2 indicates greater effect on MR signal. Cell line 2B5 shows 
no change in MR signal without induction and an approximately four-fold 
increase in R2 upon induction. Error bars are ± s.e.m. Inset shows T2-weighted 
images taken from CPMG sequence. These images show cell line 2B5 is 
capable of producing magnetic nanoparticles in sufficient quantities to create a 
visible contrast by MRI. At the shortest echo time (TE), all cells samples are 
bright, but as TE increases, cells producing nanoparticles exhibit attenuated 
signal in contrast to normal cells. The red arrow indicates the sample with the 
greatest relaxivity, 2B5 induced with doxycycline and supplemented with iron. b) 
Iron uptake in pg Fe/cell for 2B5 cells grown in various concentrations of 
doxycycline. Error bars are ± s.d. These differences are significant at p<0.05 for 
by two-tailed t-test. Inset shows results of RT-PCR detecting mRNA transcript of 
magA in 2B5 cells incubated with no dox, 0.5 µg/mL, and 2.0 µg/mL dox. c) Cell 
culture experiments indicating that a maximum R2 is achieved with a 
combination of 1.0 µg/mL doxycycline and incubation in iron for two days. Error 
bars are ± s.d. d) Iron-dosing results showing strong dependence on iron 
concentration below 200 µM Fe and less dependence above 200 µM for in vitro 
cell culture. Error bars are ± s.d. 
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To assess the iron uptake by these cells, an o-phenanthroline absorbance assay to 
measure average iron incorporated was used. The results in Figure 4.5b show an iron 
uptake of 0.59 ± .14 pg Fe/cell for cells incubated with 2 µg/mL doxycycline and 200 µM 
Fe for four days. This value fell to 0.19 ± .03 pg Fe/cell for cells incubated with 0.5 
µg/mL doxycycline and 0.04 ± .01 pg Fe/cell for cells incubated without doxycycline. 
Note that the iron uptake shows a correlation with magA expression as detected with RT-
PCR measurements shown in the inset (Figure 4.5b). This, taken together with relaxation 
rates measurements (Figure 4.5c), translates to a cellular relaxivity of R2 = 15.6 ± 1.8 
mM-1 Fe-1 in cells at 3 Tesla. The iron uptake of 0.59 ± .14 pg Fe/cell found here is 
slightly lower than, but comparable to the iron uptake for transferrin-mediated MION 
uptake (range 0.61 – 1.54 pg Fe/cell) reported previously [9]. 
 
Figure 4.5c shows MR transverse relaxivity (R2) data from doxycycline dosing 
experiments on the cell line. These studies were conducted to gain insight into the 
induction of nanoparticle formation, as well as the amount of incubation time needed in 
the presence of doxycycline and iron media supplement. Of primary concern for 
assessing the feasibility of this approach for in vivo imaging is the ability to easily induce 
cells and the ability for the nanoparticles to form within a reasonable time frame. At 0.5 
µg/mL doxycycline, the relaxivity increases from control, but reaches a plateau after one 
day of incubation with iron. At 1.0 and 2.0 µg/mL doxycycline, relaxivity increases 
nearly twice as high as with 0.5 µg/mL, to approximately 20 s-1, reaching a plateau after 
two days of incubation with iron. According to these data, a maximum effect on MR 
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signal is reached with a combination of doxycycline at 1 µg/mL and two-day incubation 
in iron media (200 µM Fe). Figure 4.5d shows results of iron dosing response. As noted 
above, the maximum R2 achieved at a doxycycline dose of 0.5 µg/mL was not as high as 
that at larger doxycycline doses, even after allowing for increased time for the 
nanoparticles to form. In order to test whether increased iron supplement can overcome 
this barrier, iron supplement was varied for cells incubated with 0.5 µg/mL doxycycline 
(24 hours induction, followed by four day iron incubation). The results in Figure 4.5d 
indicate that although at very low concentrations, R2 increases with iron concentration, it 
levels off beyond an iron concentration of 200 µM. These dosing studies indicate that 
both gene expression level and iron availability are important factors in inducing R2. 
 
In order to visualize the magnetic nanoparticles produced, electron microscopy 
was performed on the cell line after four days of induction and incubation with 200 µM 
ferric citrate (Figure 4.6). Because iron oxide is not as electron dense as gold and silver 
particles often used in electron microscopy, the iron oxide particles exhibit a moderate 
contrast in the cells. It is first noted that the particles are approximately 3-5 nm in 
diameter, spherical in shape, and homogeneous in size. Secondly, although magnetotactic 
bacteria tend to form magnetosomes in chains, here the particles do not appear in such a 
configuration. This can be expected as the anchoring of magnetosome vesicles to 
filaments within the cell, thereby creating the chain-like formations, is likely to be 
mediated by other magnetosome-related genes [103, 104]. Although the formation of 
chains and signal transduction of magnetic field into directed cell motility are necessary 
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functions for bacteria, they are not necessary for nanoparticle formation via the 





Figure 4.6: TEM images of cell line 2B5. Nanoparticles can be found within 
membrane enclosed vesicles. These vesicles, resembling endosomes, can be 
found individually (a) or in groups (b), with varying numbers of particles within, as 
can be seen when comparing vesicles in panels (b) and (d). Arrows in panel (b) 
show compartmentalization resembling the multivesicular bodies of the cellular 
degradation pathway. Particles can also be seen outside the vesicles (c), 
although they are less visible individually. Panel (e) shows uninduced cell line 





As shown in Figure 4.6, in the gene-transferred cells, although particles can be 
found throughout the cell, they are most easily identified within membrane-enclosed 
structures. This clustering, leading to effectively larger magnetic particles, may in fact 
enhance the transverse relaxation effects of the nanoparticles on the MRI signal [44]. In 
Figure 4.6, these structures are often found near one another and often near the cell 
membrane with a varying number of magnetic particles within. As marked in Figure 4.6b, 
many of these structures appear to be compartmentalized, resembling endosomes known 
as multivesicular bodies [105]. In these structures, these various compartments are known 
to indicate the sorting of material to be degraded [106], suggesting that particles here may 
be directed towards a cellular degradation pathway. 
 
Nevertheless, the exact fate of the particles produced here remains unknown. 
After MR imaging, cells incubated for an additional ten days without doxycycline or iron 
show a return to control values for relaxivity (data not shown). It is possible that, in the 
absence of new particle formation, the already-formed particles have simply been diluted 
by continued cell division. It is also possible that low pH, such as that present in maturing 
endosomes, breaks down the magnetic nanoparticles. In fact, lowering the pH to dissolve 
synthetic iron-oxide particles is often the first step in determining iron concentration for 
magnetic nanoparticles [41]. This possibility raises concern of potential adverse affects 
on cellular iron homeostasis and cell viability.  
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In order to address such concerns, a series of proliferation and cytotoxicity assays 
were performed at varying levels of gene induction with and without iron supplement. 
With a G6PD assay, no difference in the release of cytosolic G6PD was found among the 
different conditions (Figure 4.7a); as increased cytotoxicity would mean increased G6PD 
release, this result indicates absence of cytotoxicity with magA expression and iron 
uptake. Mitochondrial activity, hence cell proliferation, was assessed with a tetrazolium 
salt (MTT) assay and shows no statistically significant decrease in cell proliferation due 
to magA expression and iron uptake (Figure 4.7b). In addition, magA expression and iron 




Figure 4.7: Results of cytotoxicity assays on 2B5 cell line. a) Results of 
G6PD assay showing no increased cytotoxicity as measured by G6PD release 
into medium. b) Results of MTT assay showing no significant decrease in cell 
proliferation. c) Results of apoptosis assay showing no increase in cellular 




To further characterize these nanoparticles, they were isolated from the cells using 
magnetic separation. Specifically, the cells were ruptured by incubating in water and 
vortexing, and the particles were pulled together from the cell debris via a small, iron-
neodymium-boron magnet (Figure 4.8). In Figure 4.8b, particles can be seen aligned 
along magnetic field lines, depending on the direction of the magnet, much as what 





Figure 4.8: Magnetic nanoparticles isolated from mammalian cells. a) 
Magnetic nanoparticles can be isolated from cells by rupturing the cell membrane 
and using magnetic separation from cell debris. b) By application of a magnet 
(not seen in photo), these particles align along the field lines, in the direction of 
the magnetic field (indicated by arrow). 
 
 
Figure 4.9 shows the results of X-ray powder diffraction (XRD) analysis of these 
particles. The results show the particles consist primarily of magnetite (Fe3O4) which is 





Figure 4.9: X-ray powder diffraction analysis of isolated nanoparticles. 
Arrows indicate important magnetite peaks. Numbers in parentheses are Miller 
indices of the reflections for major peaks of magnetite. Note that raw data, 
without baseline correction, is shown and the vertical scale is logarithmic making 




The fact that a single bacterial gene can lead to the formation of magnetic 
nanoparticles in a mammalian cell is an unexpected finding, raising questions to be 
answered. For instance, the exact process of particle formation remains unknown, 
although data in existing literature may shed some light in this regard. It is known that the 
MagA protein is present in both the cytoplasmic and magnetosome membranes of M. 
magneticum strain AMB-1 [101], and recent work showing that magnetosome vesicles 
are initially formed as invaginations of the cell membrane appears to confirm this [104]. 
MagA protein in the bacteria is therefore thought to concentrate iron within the vesicle.  
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The uptake of iron into the cell, however, is likely to be dependent on the cell type 
hosting the magA gene. Tissue culture studies of human cells [107] show direct transport 
of ferrous iron, Fe(II), which is soluble at physiological pH but rapidly oxidized to ferric 
iron in an aerobic environment. For the magnetotactic bacterium, M. magneticum AMB-
1, it was found that ferrous sulphate and ferric gallate as iron sources enhanced 
magnetosome yield as compared with ferric quinate, an iron chelate often used, and it has 
been postulated that the size regulation of magnetite could be controlled by the 
coprecipitation of Fe(II) and Fe(III) via alkalization, much as can be found in in vitro 
methods [108]. The difference in iron environment of 293FT cells and magnetotactic 
bacteria is therefore one possible reason for the smaller size of the particles created here. 
In magnetotactic bacteria, magnetosomes are on the order of tens of nanometers in size 
whereas the particles here are only a few nanometers in diameter. It is also possible that 
there exist yet unknown genetic mechanisms by which specific magnetotactic bacterial 
strains are capable of maintaining their individual magnetosome dimensions. 
 
One critical question for in vivo application is whether the formation of magnetic 
nanoparticles can occur in vivo. For in vivo experiments utilizing magA expression, cells 
must be able to make use of endogenous iron sources. Although ferritin expression has 
been shown to sequester endogenous iron, suggesting the availability of ionic iron in 
vivo, the precise source of iron remains unknown. 
 
To show that the conditions for forming magnetosomes can be met in vivo, an 
experiment was conducted to demonstrate that cells can produce particles utilizing 
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endogenous iron sources after implantation. Here, cells were transplanted into the mouse 
brain. This model allows for a contralateral injection of control cells which can then be 
found on the same section by MRI and histology, in a single imaging acquisition. 
Additional rationale includes the reduced immune response of the brain, and its use in 
prior MRI studies of magnetic nanoparticle-based cell imaging [22, 93]. Uninduced 
2B5R cells (a clonal cell line derived from 2B5 cells which constitutively expresses 
DsRed, see Methods) were transplanted into the mouse brain, along with a contralateral 
control transplantation with 293FT cells inducible for GFP with doxycycline. Cells were 
allowed to grow for five days post-transplantation during which they were induced via 
continuous supply of doxycycline in drinking water and food but without iron 
supplementation and subsequently imaged. Figure 4.10a shows the results of T2*-
weighted imaging in one representative animal. On the right side of the figure (white 
arrow), magA positive cells induce significant MR signal loss while the GFP inducible 
cells, which do not express magA, do not show significant MR contrast on the 
contralateral side. The fluorescence histology in Figure 4.10b shows that GFP was in fact 
induced in control cells, confirming the delivery of doxycycline to the cells. The red 
fluorescence on the right side of Figure 4.10b confirms the presence of magA positive 
cells in conjunction with the location of these cells as seen by MRI in the figure. 
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Figure 4.10: MRI of magA cells induced in vivo. a) T2*-weighted image of 
mouse brain with transplanted magA cells (right) and GFP control cells (left) after 
5 days induction. These cells were neither induced nor incubated with iron 
supplement prior to transplantation. The magA cells (white arrow) exhibit 
significantly lower MRI signal, reflecting an increase in R2, suggesting that magA 
cells are able to use endogenous iron sources. The control cells on the left do not 
show such an effect. b) MRI of same mouse brain showing magA cells can still 
be readily seen by T2-weighted imaging, which is less sensitive than T2* with 
regard to magnetic nanoparticles. The fluorescence histology (not exactly 
registered to the MR image) confirms the presence of control (green) and magA 
positive (red) cells. Magnified green and red channels are also shown. c) T2* 
weighted MRI of transplanted 2B5R cells. Cells on the left were uninduced prior 
to the transplantation and those on the right were pre-induced in iron 
supplemented culture (magnetic particles formed in culture, prior to transplant). 
MRI images were obtained right after the transplantation. The similarity of the 
right side of Fig. 4a to that of Fig. 4c confirms that magA expression in vivo 
(utilizing endogenous iron) leads to similar MRI effects as that in iron 
supplemented culture. Fluorescence histology confirms the presence of 2B5R 
cells in both locations, however only cells on the right are capable of affecting the 
MR signal. White arrows indicate bore sites for the cell transplant. d) Brightfield 





T2*-weighted imaging is often used for cell tracking because it is more sensitive 
to the field inhomogeneities created by magnetic nanoparticles [20], but it can exaggerate 
the spatial extent of cells. In Figure 4.10b, a T2 weighted image of the same slice as 
shown in Figure 4.10a is presented. The 2B5R cells produce sufficient particles in vivo to 
be detectable by T2-weighted imaging, which, although less sensitive to magnetic 
nanoparticles, shows a more representative spatial extent of the cells and may prove 
useful for future applications where better quantification is desired. 
 
Figure 4.10c shows the results of a separate experiment intended to serve as a 
control, conducted to confirm that the observed MRI contrasts in Figure 4.10a are indeed 
due to the formation of magnetic nanoparticles in cells. In this experiment, the mouse was 
transplanted with uninduced 2B5R cells on one side (left side of image) and with 2B5R 
cells that were pre-induced and allowed to form magnetic nanoparticles in culture prior to 
transplantation on the contralateral side. Imaging was performed right after 
transplantation, without in vivo doxycycline induction. Fluorescence histology shows the 
presence of 2B5R cells on both sides, however, only induced cells on the right side are 
seen in MRI. The MRI contrast for the cells with particles formed in vitro (right side 
Figure 4.10c) is consistent with that shown on the right side of Figure 4.10a, confirming 
the particle formation (right side Figure 4.10a) in the in vivo induction experiment.  
 
The needle tracks, likely containing edema due to the trauma of the injection, can 
be seen in all cases but show much less contrast than the cells containing particles. 
Although bleeding due to the injection could potentially result in an MRI artifact 
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mimicking iron accumulation, this is unlikely the cause of contrast for the right side of 
Figures 4.10a-4.10c, as similar contrast is not found in the contralateral transplants, and 
additional histology (Figure 4.10d) shows the lack of bleeding at the site of cell 
transplantation. 
 
For in vivo applications, the lowest number of cells detectable will depend on the 
particular imaging system and resolution used. By varying the percentage of positive 
cells in cell pellets, it was found that 20% and 10% positive cells results in R2 of 13.1 ± 
1.0 and 11.1 ± 0.4 s-1 respectively. These values represent an increase of greater than 
200% over wild type making a voxel containing one in five to one in ten cells detectable 
by MRI. This suggests that a single positive cell is potentially detectable in a 50×50×50 
µm3 voxel, consistent with the findings of Weissleder et. al. [109] for transferrin-
mediated MION uptake via expression of the transferrin receptor.  
 
Taken together, these experiments demonstrate that, for the brain, expression of 
magA in vivo alters relaxivity without the addition of an exogenous iron source. Whether 











The magA gene (provided by L.E. Bertani, California Institute of Technology) 
was cloned into a doxycycline inducible lentiviral vector to control the expression of 
magA. In this way, MRI changes could be correlated with gene expression via 
doxycycline administration. magA was constructed downstream of a tetracycline response 
element (TRE) under the control of a miniCMV promoter activatable by rtTA2s-M2 
(obtained from Dr. W. Hillen). The woodchuck hepatitis virus post-transcriptional 
regulatory element (WPRE) at the 3’LTR and an HIV-flap element at the 5’LTR were 
used. Replication defective lentivirus was generated by co-transfection of this vector, 
p∆8.9 (composed of structural genes for virion assembly; obtained from Dr. C. Lois, 
MIT) and pVSV-G (Invitrogen, Inc.) into 293FT packaging cells (Invitrogen, Inc.). 
Culture medium was collected at 48 hours post transfection for 3 consecutive days at 24 
hour intervals. The supernatant was centrifuged at 25,000 × g for 90 minutes. The viral 
pellet was re-suspended, aliquoted, titered and kept frozen at -80°C. This virus was used 
to infect 293FT cells. After several cell passages to ensure stable integration, single cells 
were picked and expanded to create clonal cell lines. Clonal cell lines were produced by 
suspending 200 cells in 20 mL and distributing into two 96-well plates. Wells resulting in 
single colonies were expanded into clonal cell lines. PCR was performed to confirm the 
presence of the magA gene to identify positive lines (Figure 4.11). Three clonal lines 
were evaluated for imaging and found to produce MRI signal changes. For the following 
experiments, one of these clonal cell lines, named 2B5, was used.  
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MR Imaging of cells in culture 
For cell culture imaging (Figure 4.5a), four plates were prepared for each cell 
line: 1) no doxycycline, no iron supplement, 2) no doxycycline, but with iron supplement, 
3) with doxycycline, without iron, and 4) with doxycycline, with iron.  The appropriate 
cell samples were incubated with 2 µg/mL doxycycline and/or 200 µM Fe (from ferric 
citrate) for four days. Error bars are ± standard error of measurement (s.e.m). For dosing 
experiments (Figure 4.5c), 2B5 cells were initially cultured under normal conditions. 
Doxycycline was added to media (0.5, 1.0 and 2.0 µg/mL) for 24 hours, after which 
media was removed and replaced with fresh media supplement with 200 µM iron (from 
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ferric citrate) for 1-4 days. For iron dosing (Figure 4.5d), cells were cultured with 0.5 
µg/mL doxycycline for 24 hours, after which, media was removed and replaced with 
fresh media with varying iron concentration for four days. 
 
In all cases, cells were trypsinized and collected. 107 cells in approximately 100 µl 
pellets were imaged using a Siemens 3T Trio MR scanner. T2 times and R2 (R2≡1/T2) 
were calculated by fitting the decay curves produced from a Carr-Purcell-Meiboom-Gill 
(CPMG) imaging sequence. For dosing experiments (Figure 4.5c and 4.5d), three 
measurements were made, and error bars are ± one standard deviation (s.d.). Imaging 
parameters were: TE = 20 – 400 ms in increments of 20 ms, TR 1500 ms, FOV 128×128, 
0.5 mm in-plane, and a slice thickness of 1 mm. Image processing and analysis were 
performed using MATLAB processing software. Some statistical analysis was performed 
in Excel. 
 
Iron uptake determination: 
Iron uptake was determined using an o-phenanthroline procedure modified from a 
previously reported method [41]. 2B5 cells were grown under conditions of 0, 0.5 and 2.0 
µg/mL doxycycline and 200 µM Fe for four days. Original 293FT cells were cultured in 
the presence of 200 µM Fe for four days to serve as a baseline. 2 × 106 cells were 
counted, pelleted, resuspended in water, and vortexed to rupture cell membranes. 0.15% 
v/v mercaptoacetic acid was added to each sample and incubated overnight prior to 
analysis. o-Phenanthroline was added, reaching a final concentration of 0.0075% w/v. 
Iron solutions for a standard curve were prepared from FeSO4. Samples and standards 
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both contained 0.2% hydroxylamine hydrochloride to maintain iron in the 2+ state and 
sodium citrate (150 µL per mL of iron solution) to maintain an acidic pH for Fe-
phenanthroline complex formation. Absorbance was read at 510 nm. Iron uptake due to 
magA was determined by subtracting total iron in the 293FT sample from the 2B5 test 
samples. Samples were measured in triplicate and error bars are given by ± s.d.  
 
RT-PCR: 
2B5 cells were grown under conditions of 0, 0.5 and 2.0 µg/mL doxycycline and 
200 µM Fe for four days. First strand cDNA was created from DNase I-treated RNA 
using Superscript III (Invitrogen). Subsequent PCR was performed using Taq DNA 
polymerase (Invitrogen) over 35 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C. 
Primers utilized were forward: 5’-catcccgaactgacctatgc-3’ and reverse: 5’-
acgaacagcagcatcagc-3’ resulting in a 200 base pair amplicon. 
 
Electron microscopy: 
2B5 cells were cultured with 2 µg/mL doxycycline and 200 µM Fe for four days. 
The cells were then fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer followed 
by 1% OsO4 in the same buffer.  Cells were then dehydrated and embedded in Eponate 
resin.  Ultrathin sections (60-70 nm) of cells were observed on a Hitachi H-7500 





 103 cells per well were plated in a 96-well plate and incubated for five days under 
the various conditions of doxycycline and with and without iron supplement as indicated 
in Figure 4.7. For the glucose-6-phosphate dehydrogenase (G6PD) assay which measures 
the release of cytosolic G6PD (increased release indicates cytotoxicity), 3 wells per 
condition were measured, along with a control in which the cells are lysed to release all 
G6PD into the assay medium (for quantification). Vendor protocol was followed 
(Molecular Probes/Invitrogen, Inc.). For the tetrazolium salt (MTT) assay, 4 wells per 
condition were measured according to vendor protocol (ATCC). For the apoptosis assay, 
3 wells per condition were measured according to vendor protocol (Promega) with the 
modification of using Hoescht (5 minutes at room temperature), rather than propidium 
iodide to stain all cells (both apoptotic and nonapoptotic). Analysis was performed on 
Microsoft Excel, and error bars are ± s.d. 
 
In vivo animal experiments:  
For in vivo particle formation experiments, a clonal cell line 2B5R was 
established by infection of 2B5 with a lentivirus containing DsRed under the constitutive 
control of the CMV promoter. Single cells were plated as above to produce the clonal cell 
line, 2B5R. In this way, cells could be also tracked via fluorescence imaging. Burr holes 
were made through the dorsal skull using coordinates chosen from a standard mouse atlas 
for injection into the striatum (+ 0.4 mm anterior and +/− 1.75 mm medial/lateral relative 
to bregma, and −2.5 mm ventral from dorsal surface of brain). For Figures 4.10a and 
4.10b, uninduced 2B5R cells were transplanted into the mouse striatum shown on the 
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right. The contralateral side was transplanted with a 293FT cell line inducible for GFP, 
but not magA. In each case, the transplantation was made using a stereotaxic platform 
fitted with an automated injector and Hamilton syringe and using 105 cells suspended in a 
total volume of 4 µl in phosphate buffered saline (PBS). Cells were allowed to grow for 
five days, during which doxycycline was administered in the drinking water at 5 mg/mL 
and in the food at 200 ppm. On day 5, mice were imaged and sacrificed for histology. 
Three mice were studied with this protocol. 
 
For the control experiment (Figure 4.10c), 2B5R cells were incubated in culture 
for four days with 2 µg/mL doxycycline and 200 µM Fe. In this way, cells produced 
magnetic nanoparticles in culture, prior to transplantation. Using the transplantation 
procedure described above, 105 of these pre-induced cells were transplanted (n=2 mice) 
on the right side of the brain. On the contralateral side (left side of image), 105 uninduced 
2B5R cells were transplanted. In this case, imaging was performed immediately after 
transplantation. 
 
In all cases, imaging was performed under anesthesia (1.5% isofluorane) on a 
9.4T Bruker MR system fitted with a heated mouse cradle. MRI parameters for T2*-
weighting are: FLASH sequence, TE 6.0 ms, TR 50 ms, FOV 256×256, 88 µm in-plane, 
slice thickness 0.450 mm and for T2-weighting: spin-echo sequence, TE 10.21 ms, TR 
1000 ms, FOV 256×256, 86 µm in-plane, slice-thickness 0.654 mm. Animals were 
sacrificed post-imaging and brains collected for histology. Brains were fixed in 4% 
paraformaldehyde for one day, followed by two days in 30% sucrose. Tissue was 
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mounted in O.C.T. (Optimal Cutting Temperature) compound and 40 µm sections cut on 
a Leica CM3050S Cryostat (Nussloch, Germany). Sections were washed with PBS, 
stained with Hoechst for five minutes, and washed twice again with PBS, prior to 
mounting. Imaging was performed on an Olympus BX51 research microscope fitted with 
a Metamorph Imaging System. Figure 4.10d shows a brightfield image of the same 






The ability to produce magnetic nanoparticles in a novel host cell type opens up 
the possibility of many additional biotechnological applications. For instance, many 
molecular imaging applications envision targeting contrast agents to specific receptors or 
cell surface ligands and disease specific markers. Synthetic particles, however, are often 
non-uniform, non-homogeneous in composition, and difficult to disperse evenly in 
solution, and the production of magnetosomes for biotechnological applications has been 
limited by the sensitivity of magnetotactic bacteria to oxygen, making these strains 
difficult to isolate and maintain in culture [87]. Particles formed by the expression of 
magA are highly uniform, and could potentially replace these sources of iron oxide 
particles. Additionally, particles produced by immune matched host cells will have less 
potential for triggering immune responses because they will not display foreign 
molecules to the subject of the imaging procedure. This is an advantage over simply 
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isolating and using magnetosomes from bacterial cells, as the coating derived from 
bacteria would contain molecules foreign to other animals and humans in which the 
contrast agent may be used. It may also be possible to modify the particle for targeting 
applications with genetic manipulation, rather than chemical modification, by expressing 
magA in cell lines which also express desired ligands/receptors on their membranes so 
that isolated particles would contain these molecules on their surface, thus avoiding the 
need to chemically attach such molecules to the contrast agent. 
 
In summary, the present work sheds light on the process of natural magnetosome 
formation within the bacteria and opens up a new avenue for in vivo cellular and 
molecular imaging, including applications such as cell and transplant tracking, gene 
expression reporting by co-expressing magA with any gene of interest, and in vivo 
sensing of iron concentration. With a controllable system as described here, long-term 
MRI studies can be conducted in which uninduced cells are allowed to grow, migrate, 
divide and differentiate over a period of time in the absence of nanoparticle formation, 
minimizing the chances of the particles to interfere with normal cellular processes, and 
expression of magA can then be induced, to allow particles to form, just prior to imaging. 
Since MR imaging is non-invasive and the particles can be regenerated, magA based cell 
tracking and gene reporting allow new, longer term molecular imaging experiments not 
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